data_1jrj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jrj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.512 0.196 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 26' ' ' LEU . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.496 0.189 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.513 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.495 0.188 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.5 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.59 0.233 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 26' ' ' LEU . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.618 0.246 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.488 0.185 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.7 0.286 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.508 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.631 0.253 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.474 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 26' ' ' LEU . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.454 0.168 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.671 0.272 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.462 0.172 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.484 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.502 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.465 0.174 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.7 t . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.543 0.211 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 t . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.576 0.227 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.496 HG22 ' HD2' ' A' ' 27' ' ' LYS . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.463 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 26' ' ' LEU . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.613 0.244 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.589 0.233 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.495 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HA ' HD21 ' A' ' 26' ' ' LEU . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.496 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.501 0.191 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.528 0.204 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.455 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.571 0.224 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.48 0.181 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.504 0.192 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.553 0.216 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.378 0.132 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.1 t . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.586 0.232 . . . . 0.0 110.73 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.474 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 26' ' ' LEU . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.503 0.192 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.527 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.561 0.22 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.507 0.194 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.534 0.207 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.98 -92.95 0.1 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.641 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.6 152.46 20.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.04 70.48 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -94.19 61.07 2.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.085 0.469 . . . . 0.0 110.651 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -109.38 -32.64 7.09 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.442 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -58.33 -36.01 72.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -57.73 -47.22 83.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.29 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.64 -34.54 53.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -40.84 95.42 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.236 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -43.69 90.3 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.089 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -69.48 -44.87 70.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.707 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -55.32 -38.51 68.81 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.99 -44.42 87.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.716 0.294 . . . . 0.0 110.81 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -38.5 88.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -37.81 88.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.226 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -60.89 -40.87 94.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.02 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.57 81.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.92 -42.71 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.62 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 26' ' ' LEU . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.24 -132.71 25.75 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.03 -35.03 89.33 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.986 2.458 . . . . 0.0 112.748 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -95.24 44.5 1.09 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 t -116.57 -34.64 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.272 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.28 -42.0 1.48 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.504 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.22 40.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 111.2 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 162.71 41.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.784 2.323 . . . . 0.0 112.579 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.8 Cg_endo -70.21 139.1 37.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.796 2.331 . . . . 0.0 112.64 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 71.0 Cg_endo -74.85 90.34 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.84 2.36 . . . . 0.0 112.27 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.151 -179.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.517 0.199 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.82 64.49 0.56 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.09 136.0 48.5 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.09 -101.85 0.53 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -149.34 62.3 1.03 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.741 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.27 12.74 8.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.121 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -81.62 -51.33 8.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -68.45 -35.93 78.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.22 -40.25 71.23 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.305 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -61.2 -35.8 78.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -62.71 -42.95 99.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.82 -34.66 39.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.254 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -69.08 -47.65 64.69 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.363 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.1 -40.31 89.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.97 -43.28 71.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.258 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.5 -46.92 71.5 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -61.53 -37.01 82.19 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.087 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.76 92.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.146 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.1 t -64.57 -44.92 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.576 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.513 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.82 -130.69 17.59 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.01 -26.88 73.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.986 2.458 . . . . 0.0 112.818 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.75 46.3 1.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.289 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -136.37 11.13 3.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.0 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.36 35.59 92.27 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.675 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.05 137.34 9.96 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 120.651 0.262 . . . . 0.0 111.257 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.66 157.71 60.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.695 2.263 . . . . 0.0 112.702 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 61.3 Cg_endo -72.32 141.62 35.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.735 2.29 . . . . 0.0 112.396 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.52 -36.18 35.21 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.694 2.263 . . . . 0.0 112.403 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.928 179.763 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.67 0.271 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.17 119.6 2.55 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.83 144.37 30.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.705 0.288 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -53.27 0.59 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 t -115.56 67.7 0.71 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.181 0.515 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -98.87 -29.05 13.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.37 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -63.4 -25.63 68.37 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.764 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -57.69 -52.4 65.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.734 0.302 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.05 -35.04 43.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.962 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.98 -39.12 91.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.215 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -61.03 -40.43 93.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.247 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.79 -43.91 97.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.307 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -73.67 -42.3 61.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.177 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.1 90.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.025 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -44.99 95.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.34 -41.83 90.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.21 -40.33 95.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.79 87.81 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.346 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.2 t -61.05 -38.43 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.821 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.511 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.57 -135.59 19.65 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.6 -33.05 93.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.897 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.26 41.39 1.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.732 0.301 . . . . 0.0 111.685 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -113.12 -34.73 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.52 -47.54 0.97 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.713 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.82 40.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.291 . . . . 0.0 111.254 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 165.19 32.05 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.765 2.31 . . . . 0.0 112.569 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.9 Cg_endo -68.32 153.03 75.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.758 2.305 . . . . 0.0 112.722 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 86.7 Cg_endo -89.14 43.68 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.247 2.632 . . . . 0.0 112.644 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.063 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.1 p80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.19 178.45 43.58 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.2 156.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 111.42 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.8 62.76 0.93 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.475 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -94.93 39.63 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.345 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 -33.82 26.07 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.245 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -61.27 -35.2 76.66 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.454 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -77.1 -36.23 55.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.668 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.52 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.644 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -40.6 88.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -62.65 -33.28 74.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.927 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -40.99 96.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.968 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -67.01 -47.79 70.38 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 7.0 mtt -63.72 -40.11 95.95 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.663 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -64.88 -38.77 92.1 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.77 -40.85 76.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.065 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.24 -39.52 94.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.854 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.67 94.65 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.123 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -64.81 -45.47 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.252 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.529 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.404 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.11 -133.74 13.36 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.17 -31.18 94.89 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.74 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 t -101.8 32.91 3.2 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 28' ' ' ASN . 41.4 t -97.32 -38.48 9.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.502 0.191 . . . . 0.0 110.911 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.47 -60.45 0.42 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.523 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.84 163.37 24.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.52 164.4 35.44 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.529 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.6 Cg_endo -68.12 125.86 13.61 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.586 2.191 . . . . 0.0 112.756 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.2 Cg_endo -78.03 121.87 5.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.885 2.39 . . . . 0.0 112.392 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.143 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.517 0.198 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.35 -59.57 0.56 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.78 87.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.18 2.83 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.42 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -120.44 45.06 2.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -16.01 43.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.872 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -54.77 -39.65 68.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.672 0.272 . . . . 0.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 m -90.26 -34.78 15.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.105 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -61.89 -42.79 99.49 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -46.21 90.09 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -61.96 -41.32 97.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.124 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -70.46 -39.13 74.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.224 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -58.43 -42.57 87.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.057 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.11 -42.11 76.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.93 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -33.47 71.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.341 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -56.32 -36.28 68.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.541 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.93 -46.19 90.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 111.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -43.89 90.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.08 -38.65 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' HA ' ' CG ' ' A' ' 38' ' ' PRO . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.74 -129.59 48.65 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.73 -34.18 63.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.767 2.312 . . . . 0.0 112.564 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -27.51 69.13 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.83 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -56.18 -35.81 67.65 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.87 -47.35 1.02 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.52 151.72 59.33 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.588 0.232 . . . . 0.0 111.383 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.55 163.32 37.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.722 2.282 . . . . 0.0 112.243 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB3' ' CZ3' ' A' ' 25' ' ' TRP . 38.5 Cg_endo -66.31 146.6 81.35 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.556 2.171 . . . . 0.0 112.817 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' CG ' ' HA ' ' A' ' 22' ' ' PHE . 48.4 Cg_endo -68.71 159.14 54.91 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.021 2.48 . . . . 0.0 112.712 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.226 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.47 0.176 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.93 44.08 1.58 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.697 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -149.66 87.73 1.51 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.45 58.04 0.41 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.525 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -142.13 85.21 1.91 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.464 ' O ' ' HB ' ' A' ' 7' ' ' THR . 21.6 m-85 -106.14 -62.99 1.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.024 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.3 m 73.53 -57.94 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.405 0.682 . . . . 0.0 111.098 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 m -94.22 -40.16 10.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.812 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -70.09 -32.99 71.31 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.022 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.67 -41.15 98.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 m -62.53 -42.87 99.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.995 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.84 -43.16 76.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.3 93.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.1 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.0 mtt -59.69 -41.17 90.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.85 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -61.99 -38.47 88.74 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.712 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.2 -37.38 82.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.005 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.01 -44.5 82.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.91 90.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.62 -39.77 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 -130.32 9.72 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.86 -24.65 79.66 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.842 2.361 . . . . 0.0 112.805 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -98.49 34.51 2.0 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -99.29 -35.06 10.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.059 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.92 -42.95 1.24 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -109.37 158.0 35.73 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 36.7 Cg_endo -65.68 163.8 29.03 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.73 2.287 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.7 Cg_endo -66.27 134.62 36.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.71 2.273 . . . . 0.0 112.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 73.9 Cg_endo -75.23 155.63 41.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.921 2.414 . . . . 0.0 112.521 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.219 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.13 94.29 0.7 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.496 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.04 95.52 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.87 57.39 4.07 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.531 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.6 t -141.64 49.02 1.61 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.226 0.536 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.95 11.76 17.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.946 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -104.26 -39.68 6.4 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.527 0.203 . . . . 0.0 111.075 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.6 p -68.37 -50.0 56.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.528 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -67.85 -42.56 81.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -63.88 -32.56 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -37.92 85.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.069 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -62.58 -51.21 68.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.118 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -69.73 -38.56 76.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.448 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -38.06 89.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.85 -43.79 97.85 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.821 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.49 -44.4 62.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.792 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.06 -39.69 90.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.108 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.93 94.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.32 -43.54 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.381 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.483 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 26' ' ' LEU . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.79 26.45 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -30.93 79.2 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.908 2.406 . . . . 0.0 112.673 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 p -95.0 33.22 1.54 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -108.57 -32.87 7.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.196 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.74 -47.07 1.03 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.778 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.76 154.12 42.17 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.701 0.286 . . . . 0.0 111.196 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.86 164.0 36.81 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.805 2.336 . . . . 0.0 112.642 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 41.5 Cg_endo -68.12 134.97 33.21 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.708 2.272 . . . . 0.0 112.705 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.7 Cg_endo -72.76 94.69 0.79 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.929 2.419 . . . . 0.0 112.224 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.188 -179.802 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.88 -113.88 2.18 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.643 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.74 139.54 37.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.28 80.55 0.2 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.912 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.51 32.73 18.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.851 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER 61.09 17.44 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.909 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -107.14 -42.98 4.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.13 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -37.68 88.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.88 -39.7 23.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.313 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -63.62 -39.42 94.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.232 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.1 p -60.99 -37.6 83.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.033 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -63.58 -43.84 95.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.837 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -69.65 -41.23 75.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.2 mmt -58.16 -47.23 84.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -63.85 -38.13 89.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -40.22 84.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.333 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -59.58 -42.27 92.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.207 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.06 93.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 19.9 t -63.82 -41.53 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.498 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' HA ' ' CG ' ' A' ' 38' ' ' PRO . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.77 -132.06 28.99 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.42 -30.11 79.96 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.951 2.434 . . . . 0.0 112.842 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -99.5 39.51 1.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -112.25 -32.93 6.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.44 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.53 -46.04 1.06 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.633 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.44 154.88 37.38 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.374 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.14 166.82 27.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.879 2.386 . . . . 0.0 112.551 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.11 146.09 75.42 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.74 2.293 . . . . 0.0 112.9 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 84.1 Cg_endo -76.66 -17.81 15.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.097 2.531 . . . . 0.0 113.161 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.2 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.57 -163.0 36.79 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.764 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.96 153.83 49.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.47 71.25 0.33 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.362 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m 63.62 78.57 0.29 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -77.28 -27.24 53.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.429 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -53.45 -34.09 56.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.575 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -57.82 -46.32 84.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.67 0.272 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.24 -32.7 63.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.988 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.96 -43.56 94.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.309 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -45.84 92.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -67.57 -40.24 84.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -64.16 -45.23 89.32 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -40.22 83.36 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -70.32 -47.0 63.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.055 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -46.06 87.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.194 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -61.88 -38.62 88.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.815 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.48 94.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.11 -44.94 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 -133.33 20.86 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.81 -32.22 95.12 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.714 2.276 . . . . 0.0 112.593 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -98.27 26.17 5.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.1 t -88.97 -39.18 13.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 110.901 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 149.6 -46.85 0.64 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.49 164.09 15.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.655 0.264 . . . . 0.0 111.154 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.4 164.53 34.85 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.715 2.277 . . . . 0.0 112.5 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.8 Cg_endo -65.96 134.44 37.19 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.731 2.287 . . . . 0.0 112.44 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.4 Cg_endo -71.67 101.72 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.792 2.328 . . . . 0.0 112.177 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.227 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.3 p80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.739 0.305 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.9 125.7 3.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.595 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.18 169.51 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.802 0.334 . . . . 0.0 111.278 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.19 85.14 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.78 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -105.34 35.81 2.71 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.127 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -71.55 -31.73 67.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.066 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -94.71 -24.38 17.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.435 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -80.95 -54.12 5.85 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -43.24 98.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.734 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -62.13 -35.29 78.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.138 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -62.55 -42.84 99.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.708 0.29 . . . . 0.0 110.884 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -72.28 -43.79 63.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -39.52 91.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.142 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.69 -40.46 92.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.6 -35.41 80.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.022 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -39.82 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.024 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.78 -41.05 94.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.822 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.29 95.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.8 t -63.61 -44.17 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.441 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 38' ' ' PRO . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.508 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.12 -135.56 22.86 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.48 -30.97 80.57 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.718 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -95.88 30.94 2.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -106.37 -32.84 7.96 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.213 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.51 -45.12 1.17 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.94 45.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 120.55 0.214 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.56 162.85 40.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.69 2.26 . . . . 0.0 112.639 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 144.53 53.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.622 2.215 . . . . 0.0 112.68 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' CG ' ' HA ' ' A' ' 22' ' ' PHE . 27.3 Cg_endo -62.24 -41.5 34.3 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.835 2.357 . . . . 0.0 112.376 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.902 179.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.57 0.224 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.69 -102.36 1.77 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.573 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.86 158.91 43.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.13 -106.7 0.88 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.588 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 t -151.58 89.73 1.51 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.141 0.496 . . . . 0.0 110.699 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -9.93 56.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.003 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -55.25 -45.72 76.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.683 0.278 . . . . 0.0 111.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -88.97 -33.1 17.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.251 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -63.56 -37.08 85.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.799 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -43.97 95.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.345 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -61.05 -40.58 94.16 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.636 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -40.37 62.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -50.53 70.52 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.63 -39.34 87.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.93 -41.84 95.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.032 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.13 -46.32 90.04 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.468 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -38.44 87.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.681 0.276 . . . . 0.0 110.935 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.21 98.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.22 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 t -63.05 -42.47 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.542 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.552 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.453 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.83 -128.07 39.8 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.5 -30.5 90.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.676 2.25 . . . . 0.0 112.568 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -96.21 33.71 1.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 t -96.21 -39.03 9.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.908 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.83 -46.28 0.71 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.619 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.41 164.0 16.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.87 165.14 26.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.654 2.236 . . . . 0.0 112.541 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -65.82 130.71 25.34 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.8 2.333 . . . . 0.0 112.6 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.3 Cg_endo -73.62 142.44 32.57 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.839 2.359 . . . . 0.0 112.324 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.444 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.894 0.378 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 64.57 0.04 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.578 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.08 156.2 20.86 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.793 0.33 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.73 -86.16 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.466 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 m 70.87 104.12 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.242 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.39 11.12 7.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.504 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -96.25 -55.21 3.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.71 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.5 t -77.58 -39.18 46.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.861 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.3 -44.15 95.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -38.82 92.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.695 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -61.78 -40.04 93.8 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.786 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -41.33 99.52 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.739 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -62.16 -47.2 85.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -39.04 93.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -37.38 87.24 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.047 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.99 -39.41 94.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.8 92.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.42 -43.16 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.27 -129.66 31.72 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.58 -29.53 70.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.719 2.279 . . . . 0.0 112.782 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -92.5 33.93 1.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -111.23 -29.11 7.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.471 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.45 33.95 2.19 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.682 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.63 148.27 3.28 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.52 0.2 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.41 159.76 52.43 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.514 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.73 140.43 46.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.683 2.255 . . . . 0.0 112.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.9 Cg_endo -71.18 117.41 5.14 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.847 2.365 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.474 0.178 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.72 -124.14 2.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.658 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -152.37 146.39 25.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.929 0.395 . . . . 0.0 111.323 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 10.87 83.11 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.206 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.8 p -113.93 51.44 0.87 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.021 0.438 . . . . 0.0 110.592 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' O ' ' HB ' ' A' ' 7' ' ' THR . 12.7 m-85 -120.84 -60.97 1.61 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.948 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 71.1 m 74.19 -55.82 0.65 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.246 0.618 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -80.48 -41.99 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 26.4 t70 -63.68 -44.17 94.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.179 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -38.56 89.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m -61.56 -39.16 90.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.075 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -48.3 60.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -60.58 -36.4 78.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.0 mmt -57.58 -39.15 76.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.229 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -62.48 -47.02 85.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.221 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.16 -45.5 93.16 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.29 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.7 -38.41 84.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.05 91.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.348 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.08 -41.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.464 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.524 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 26' ' ' LEU . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.52 -132.79 27.49 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.14 -31.57 83.03 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.931 2.421 . . . . 0.0 112.711 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 m -96.39 40.94 1.12 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 111.73 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -114.53 -33.88 5.41 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.236 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.65 -46.62 1.05 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.801 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.09 154.96 45.09 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 111.3 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.39 162.67 40.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.844 2.363 . . . . 0.0 112.678 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 57.0 Cg_endo -70.49 128.86 15.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.762 2.308 . . . . 0.0 112.674 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 68.7 Cg_endo -75.98 101.32 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.822 2.348 . . . . 0.0 112.517 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.127 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.734 0.302 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.19 140.4 7.46 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.438 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.32 133.89 11.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.669 0.271 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.85 84.19 0.19 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.624 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t 42.32 46.19 3.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -42.71 8.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.709 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -65.26 -44.36 88.34 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -63.36 -39.16 93.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.966 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -41.19 69.31 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.188 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.46 -43.72 98.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.078 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 t -63.58 -40.99 98.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -71.46 -40.47 70.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.48 -45.97 92.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.1 mtp -57.07 -46.07 82.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.22 -44.01 85.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.94 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.85 88.63 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -39.75 92.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.813 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.13 89.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.71 -42.34 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -131.02 30.18 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.12 -27.03 73.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.938 2.425 . . . . 0.0 112.905 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -95.47 21.23 8.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -96.89 -33.04 11.76 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.464 0.173 . . . . 0.0 111.108 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.88 -51.39 0.86 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.6 60.01 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.0 162.22 43.03 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.697 2.265 . . . . 0.0 112.628 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.6 Cg_endo -69.02 138.05 39.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.684 2.256 . . . . 0.0 112.56 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 57.1 Cg_endo -71.33 118.96 5.94 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.846 2.364 . . . . 0.0 112.623 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.688 0.28 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.07 -141.45 3.13 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.687 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.19 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 111.427 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.81 -52.66 0.76 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.637 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -130.9 40.61 3.46 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.1 -28.45 16.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.387 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -56.19 -36.18 68.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.663 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -44.47 92.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.83 -37.8 34.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -42.49 98.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.213 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -62.72 -42.64 99.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -68.96 -42.72 76.27 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.9 -40.02 95.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -61.35 -39.95 92.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.54 -41.56 98.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.24 -40.41 81.67 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.11 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.1 -41.33 92.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.143 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.94 97.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.977 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.5 t -62.72 -40.85 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.442 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.487 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.69 -132.13 24.31 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.79 -35.73 66.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.965 2.443 . . . . 0.0 112.534 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -94.99 42.46 1.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 111.716 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 t -116.31 -33.19 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.22 36.08 1.69 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.424 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.45 145.82 4.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.561 0.219 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.51 156.77 64.74 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.596 2.198 . . . . 0.0 112.682 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 59.5 Cg_endo -70.83 142.84 44.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.859 2.372 . . . . 0.0 112.435 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.46 104.89 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.772 2.315 . . . . 0.0 112.364 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.032 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.832 0.348 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.59 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 62.57 89.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 111.275 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.26 69.5 0.05 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.678 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -116.46 50.97 1.01 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.123 0.487 . . . . 0.0 110.838 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -162.0 79.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.13 0.967 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -111.29 -40.9 4.28 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 p -69.02 -44.73 72.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.149 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.28 87.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.11 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.04 -45.94 89.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -63.04 -38.75 92.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -67.31 -40.16 85.99 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 46.7 mt-30 -65.75 -33.25 75.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.265 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 46.6 mtp -68.24 -33.23 74.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.686 0.279 . . . . 0.0 110.832 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -72.71 -47.15 49.53 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.821 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.0 -35.61 75.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.366 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -36.41 67.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.895 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.8 -35.99 79.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.048 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.11 -43.77 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.668 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' CG ' ' A' ' 38' ' ' PRO . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.492 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.23 -130.26 35.09 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.13 -28.96 80.35 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.865 2.377 . . . . 0.0 112.703 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -97.13 40.82 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.673 0.273 . . . . 0.0 111.708 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -114.2 -33.86 5.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.21 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.07 -47.58 0.96 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.705 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.94 154.07 37.52 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.668 0.271 . . . . 0.0 111.304 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.59 168.36 20.09 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 35.1 Cg_endo -64.9 153.59 77.33 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.67 2.247 . . . . 0.0 112.8 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 89.4 Cg_endo -81.98 -1.33 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.148 2.565 . . . . 0.0 113.491 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.713 -0.661 . . . . 0.0 111.448 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.615 0.245 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.44 0.24 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.523 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.36 119.79 22.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.25 56.28 0.1 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.455 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 p -138.89 46.9 1.95 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.723 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.07 -32.42 63.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.625 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -61.68 -48.44 80.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.2 p -65.47 -40.36 93.06 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -36.12 80.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.23 -39.19 93.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.924 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -60.69 -44.39 96.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.087 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -75.71 -37.04 59.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.252 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.47 -43.6 98.58 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.19 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mtt -59.3 -45.78 90.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.964 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.24 -42.93 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.12 -42.1 98.89 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -38.83 87.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.039 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.03 88.59 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t -61.04 -52.08 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.452 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.502 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.411 ' HE2' HG21 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.502 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 -131.84 31.95 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.86 -31.88 77.55 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.919 2.413 . . . . 0.0 112.755 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -96.29 40.95 1.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.712 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 t -113.34 -31.26 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.22 32.78 2.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.605 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.42 148.06 4.05 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.618 0.247 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.64 158.33 58.17 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.598 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -69.17 138.29 39.31 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.764 2.309 . . . . 0.0 112.252 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.493 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 49.2 Cg_endo -69.04 109.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.738 2.292 . . . . 0.0 112.498 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.037 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.66 -137.11 12.61 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.677 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -130.4 143.53 50.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.71 49.23 1.11 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.73 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m 59.34 86.74 0.09 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.272 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -66.41 -31.23 71.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -60.65 -34.24 73.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.353 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -56.71 -48.2 78.24 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.057 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.7 -36.88 62.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.064 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -38.82 82.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -47.4 85.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -70.41 -40.91 73.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -57.88 -43.07 85.82 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -42.69 93.45 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.73 -39.68 88.07 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -43.23 96.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.995 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -39.27 91.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.981 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.32 83.71 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.113 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.684 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.92 -126.45 38.84 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.05 -31.72 93.82 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.646 2.231 . . . . 0.0 112.423 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.36 50.76 1.26 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 m -112.61 -39.39 4.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.53 -40.11 1.24 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.4 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -115.96 161.65 29.79 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.33 165.15 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 0.0 112.344 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 29.5 Cg_endo -63.2 132.3 35.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.65 2.233 . . . . 0.0 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.482 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.1 Cg_endo -70.54 134.15 25.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.803 2.336 . . . . 0.0 112.593 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.904 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.4 m80 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.515 0.197 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.61 62.32 0.43 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.58 137.12 33.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 111.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.65 -53.99 2.31 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.551 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 62.09 32.11 17.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.714 0.292 . . . . 0.0 111.245 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.74 15.56 5.96 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -103.94 -51.91 3.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.252 . . . . 0.0 111.117 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p -65.72 -40.12 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.22 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.12 -41.59 77.17 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.03 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.57 98.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -42.0 98.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.736 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.09 89.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -67.31 -38.52 85.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mtt -60.36 -40.15 89.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.884 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.65 -41.2 94.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.98 -40.32 97.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.805 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.72 -39.22 87.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.784 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.32 82.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.46 -45.3 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.47 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.02 -132.6 11.22 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.05 -30.19 90.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.829 2.353 . . . . 0.0 112.684 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -100.84 41.25 1.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.727 0.298 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.1 -35.63 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.294 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.31 -52.85 0.59 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.572 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.406 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . . . -102.04 159.09 30.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 35' ' ' ALA . 39.6 Cg_endo -67.13 163.88 32.38 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -64.92 128.46 20.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.71 2.273 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 63.6 Cg_endo -74.06 145.97 36.16 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.86 2.374 . . . . 0.0 112.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.002 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.718 0.294 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.64 90.49 2.03 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.442 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 155.26 49.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.18 -43.74 1.34 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.7 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -119.35 73.23 0.94 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.051 0.453 . . . . 0.0 110.785 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 7' ' ' THR . 43.3 m-85 -68.55 -51.31 44.24 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.742 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 98.7 m 74.01 -55.5 0.66 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.5 p -78.55 -47.98 16.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.471 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.19 -41.03 43.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.368 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -38.37 88.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -63.92 -43.7 95.13 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.243 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.68 -40.13 76.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.46 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -68.55 -44.0 75.45 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.482 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.33 -44.46 95.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.311 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -67.39 -41.03 85.64 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.42 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.26 -41.81 80.54 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.456 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.63 -40.73 95.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.155 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.31 86.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 t -62.52 -41.17 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.585 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.477 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.09 -128.6 25.72 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.78 -28.55 86.64 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.641 2.228 . . . . 0.0 112.559 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -98.73 24.02 8.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -86.58 -26.62 24.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.374 0.131 . . . . 0.0 111.087 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.31 31.07 2.71 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.846 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -176.65 156.36 1.39 Allowed Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.593 0.235 . . . . 0.0 110.927 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.71 157.74 60.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.484 2.122 . . . . 0.0 112.303 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.477 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 48.3 Cg_endo -67.97 134.02 30.78 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.6 Cg_endo -74.73 84.14 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.758 2.305 . . . . 0.0 112.28 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.086 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 p80 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.11 176.89 39.04 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.45 96.07 2.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.69 -44.74 7.13 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.617 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.44 71.72 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.091 0.472 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -122.93 12.06 9.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.846 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -101.25 -50.21 3.84 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 110.723 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.7 t -83.04 -40.7 19.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.212 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.96 -46.89 79.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -41.09 94.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -62.89 -44.79 95.16 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -69.21 -36.54 77.38 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.162 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -49.99 75.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 mtt -58.6 -39.48 80.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.913 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.35 -45.69 79.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.967 179.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.69 -45.87 90.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.209 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.08 -36.82 82.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.23 90.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.86 -42.88 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.742 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.442 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.496 HG22 ' HD2' ' A' ' 27' ' ' LYS . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 26' ' ' LEU . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.74 -132.37 34.59 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.4 -31.78 81.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.945 2.43 . . . . 0.0 112.639 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.84 38.72 1.16 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.69 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 t -111.81 -33.64 6.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.213 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.15 1.24 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.608 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.96 153.36 41.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 111.265 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.72 163.74 37.95 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.823 2.349 . . . . 0.0 112.49 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.21 142.42 55.43 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.686 2.257 . . . . 0.0 112.593 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 73.6 Cg_endo -76.14 169.88 21.17 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.955 2.437 . . . . 0.0 112.626 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.965 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.731 0.3 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.89 -105.0 2.49 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 55.55 61.33 2.89 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.97 -45.47 1.0 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.722 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m 60.36 50.43 6.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.52 -30.76 18.01 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.562 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 m -60.28 -40.22 89.62 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.481 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.091 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.6 -36.58 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.276 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.86 -40.19 91.97 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.304 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -60.39 -44.24 95.86 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -40.96 66.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -50.63 72.69 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 mtm -57.06 -41.53 78.93 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.01 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.51 -37.4 85.88 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.949 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.38 76.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.31 -40.94 97.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.836 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.65 88.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.27 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.21 -46.84 89.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.577 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.498 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.35 -129.59 45.64 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.08 -27.56 84.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.838 2.359 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -94.92 42.65 1.09 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.725 0.298 . . . . 0.0 111.555 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -115.82 -34.59 4.75 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.14 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.65 -43.1 1.34 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.623 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.1 153.91 39.0 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 111.36 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.69 165.22 30.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.784 2.323 . . . . 0.0 112.627 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 138.67 43.39 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.715 2.277 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 55.8 Cg_endo -70.65 131.14 19.41 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.894 2.396 . . . . 0.0 112.402 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.759 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 m170 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.753 0.311 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.9 -54.24 0.21 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -135.12 97.48 3.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.41 -77.91 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.85 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m 58.24 43.19 20.68 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 110.955 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -82.46 -27.9 31.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.413 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 m -51.11 -34.37 30.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.779 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.4 p -55.98 -41.47 74.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.189 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.58 -34.77 27.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -42.64 98.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.368 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -61.85 -41.03 97.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.99 -40.15 63.17 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -44.71 89.55 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.225 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -59.51 -43.66 93.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -66.8 -42.46 85.93 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.778 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.05 -44.63 87.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -39.73 92.71 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.005 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.28 86.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.89 -44.88 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.666 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' HA ' HD21 ' A' ' 26' ' ' LEU . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.25 -132.02 27.74 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.93 -28.78 75.43 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.913 2.408 . . . . 0.0 112.684 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 32.1 2.29 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 t -106.1 -34.02 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.033 179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.99 -45.65 1.1 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.712 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.92 153.81 39.86 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.17 165.9 29.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.685 2.257 . . . . 0.0 112.525 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.3 Cg_endo -67.05 149.71 82.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.725 2.284 . . . . 0.0 112.755 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 85.0 Cg_endo -82.55 -175.51 2.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.107 2.538 . . . . 0.0 112.724 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.936 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.64 0.257 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 74.46 0.24 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -111.45 135.92 51.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.52 63.55 2.58 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.592 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.3 p -139.38 68.37 1.37 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.603 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 34.3 m-85 -141.79 -62.07 0.46 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.049 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 83.8 m 74.63 -56.99 0.62 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.247 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -87.3 -41.71 13.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -76.6 -34.78 58.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.164 179.807 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 2.6 tt -65.98 -45.51 81.41 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.921 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 p -62.57 -38.75 91.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.975 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -43.19 75.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -65.22 -43.55 91.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.7 mmt -60.87 -39.06 87.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.803 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -45.63 93.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -35.8 78.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -44.37 95.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.207 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.09 99.67 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.2 t -62.11 -42.45 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.576 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.496 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.496 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.33 -131.48 27.23 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.65 -28.64 76.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 m -88.53 48.68 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 111.254 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -138.69 11.36 2.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.989 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.27 92.64 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.735 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.88 137.61 10.24 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.67 0.271 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.61 157.54 61.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.599 2.199 . . . . 0.0 112.825 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 63.4 Cg_endo -73.24 146.13 40.03 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.853 2.369 . . . . 0.0 112.689 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.545 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 96.5 Cg_endo -85.49 54.73 3.78 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.089 2.526 . . . . 0.0 112.318 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.805 0.336 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.52 -65.59 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.786 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -109.78 150.46 28.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.96 93.06 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m 69.9 103.02 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.742 0.306 . . . . 0.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.19 -70.29 0.76 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 96.7 m 71.28 -56.82 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.176 0.59 . . . . 0.0 111.265 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -38.84 66.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.506 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.561 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -60.21 -38.54 83.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.939 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.11 -41.55 98.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.524 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.58 -41.77 91.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.162 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -44.74 76.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -64.34 -47.64 78.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -41.03 82.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -45.27 94.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.768 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.89 -40.05 87.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -62.68 -40.58 97.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.933 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.59 89.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.004 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.51 -43.39 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.699 179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.05 -129.26 34.92 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.31 -28.2 78.56 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -96.84 37.74 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.691 0.281 . . . . 0.0 111.692 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 t -113.96 -32.2 6.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.297 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.52 -45.32 1.15 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.719 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.35 153.65 44.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.702 0.287 . . . . 0.0 111.356 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 162.95 40.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.832 2.355 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 50.4 Cg_endo -69.12 136.98 36.17 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 112.635 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.9 Cg_endo -72.88 108.54 2.6 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.763 2.309 . . . . 0.0 112.207 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.859 -179.937 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.593 0.235 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.96 -93.79 0.19 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.468 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -136.06 154.02 51.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.81 0.338 . . . . 0.0 111.481 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.97 -76.34 0.95 Allowed Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.581 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 57.49 41.15 26.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -101.48 -29.74 11.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.423 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -57.21 -34.85 68.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.547 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -44.26 90.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.104 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -76.34 -38.31 56.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.267 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.78 88.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.226 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -70.47 -32.32 69.8 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.746 0.307 . . . . 0.0 110.709 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -74.87 -44.97 46.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.683 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -59.88 -41.68 92.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.492 0.187 . . . . 0.0 111.314 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 20.1 mmt -68.45 -34.77 76.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.586 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -44.29 68.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.42 -44.63 95.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.83 -41.12 97.4 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.997 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.74 97.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.64 -43.01 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.479 179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.521 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.517 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.67 -129.11 49.16 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 -33.48 92.81 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.964 2.443 . . . . 0.0 112.824 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t -91.0 53.32 2.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.973 0.416 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 t -122.62 -37.24 2.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.21 -41.27 1.44 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.486 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.78 154.91 37.66 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.66 0.267 . . . . 0.0 111.263 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 164.9 32.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.698 2.265 . . . . 0.0 112.659 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.517 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 51.9 Cg_endo -69.57 133.65 26.44 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.758 2.305 . . . . 0.0 112.631 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 54.6 Cg_endo -70.61 -40.47 3.97 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.756 2.304 . . . . 0.0 112.466 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.04 179.764 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.103 0.477 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.02 111.73 1.72 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.09 165.67 13.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 111.269 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 62.9 0.2 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.576 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m 57.32 62.35 2.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.056 0.455 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -91.73 -29.62 16.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.415 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -57.21 -37.11 71.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.563 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -60.08 -46.63 88.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.89 -34.65 64.5 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.149 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 3.2 tt -63.78 -41.09 98.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.991 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.8 m -68.08 -25.39 65.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.124 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -81.06 -47.29 13.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.437 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 10' ' ' LEU . 3.4 pp0? -62.88 -40.09 96.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.455 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -32.43 70.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.905 179.483 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -69.96 -40.61 75.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.904 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.21 -39.96 76.5 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.27 -39.79 91.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.225 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.48 88.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.66 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.699 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.555 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.454 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.8 -126.76 39.82 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.39 -28.59 87.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.678 2.252 . . . . 0.0 112.703 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -98.34 30.75 3.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -91.88 -39.33 11.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.5 0.19 . . . . 0.0 110.882 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.82 -44.89 0.84 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.592 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . . . -110.8 164.95 13.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.993 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -68.06 164.76 30.74 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.454 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 36.8 Cg_endo -65.99 126.67 16.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.69 2.26 . . . . 0.0 112.539 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 65.8 Cg_endo -75.55 106.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.815 2.343 . . . . 0.0 112.204 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.636 -179.772 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.494 0.188 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.8 54.31 0.57 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.709 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 1.9 tp10 -167.8 146.62 4.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 111.315 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.05 110.44 2.7 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.18 179.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 m 67.66 99.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.725 0.41 . . . . 0.0 112.046 179.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.26 12.93 6.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 3' ' ' GLU . 1.6 m -105.43 -44.25 4.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.628 0.251 . . . . 0.0 110.884 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -68.94 -43.61 74.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.41 -46.63 75.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.879 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -61.89 -40.37 95.19 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.896 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -42.29 86.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.988 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -66.34 -45.16 81.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 44.4 mtm -61.73 -45.77 92.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.932 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -35.44 80.08 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -42.82 83.99 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.142 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.2 -41.91 94.01 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.32 96.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.1 t -63.55 -43.93 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.314 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.452 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.76 -133.7 16.02 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.73 -29.31 89.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.856 2.371 . . . . 0.0 112.566 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -102.02 23.71 11.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 t -87.37 -38.82 15.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.538 0.209 . . . . 0.0 110.982 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.58 -45.67 0.71 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.596 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.22 162.85 18.8 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.687 0.28 . . . . 0.0 111.242 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.34 165.64 29.78 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.759 2.306 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.7 Cg_endo -66.04 138.39 52.11 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.74 2.294 . . . . 0.0 112.582 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -71.75 116.55 4.75 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.803 2.336 . . . . 0.0 112.548 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.781 179.871 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.703 0.287 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.07 52.72 50.34 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -104.06 154.95 19.1 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.45 -56.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.559 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m 62.8 79.93 0.24 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -94.88 11.38 31.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -103.49 -36.69 7.88 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.559 0.218 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -87.72 -47.34 8.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.233 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.18 -48.88 66.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.524 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -39.69 91.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.066 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 t -64.98 -40.16 94.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.033 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -66.9 -40.11 87.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.014 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.73 -43.93 78.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 28.8 mtt -67.47 -24.77 65.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.569 179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -84.31 -37.02 22.16 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.19 -44.64 94.81 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.476 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -35.02 72.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.265 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.34 86.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t -59.82 -48.23 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.66 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.12 -133.24 14.62 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.09 -29.87 90.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.77 2.314 . . . . 0.0 112.643 179.786 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -99.86 17.24 21.32 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -80.0 -39.58 29.72 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.506 0.193 . . . . 0.0 110.87 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.79 -48.26 0.62 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.469 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.18 161.55 22.61 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.48 165.62 26.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.734 2.29 . . . . 0.0 112.457 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.6 Cg_endo -65.85 143.15 72.31 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.732 2.288 . . . . 0.0 112.836 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.4 Cg_endo -80.87 67.71 8.56 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.988 2.459 . . . . 0.0 112.47 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.021 -179.96 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.492 0.186 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.3 -82.81 1.61 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.403 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -111.32 98.41 7.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.06 1.06 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 t -156.79 38.55 0.32 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.926 0.393 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.72 -44.8 4.98 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -72.96 -44.88 60.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -63.55 -42.73 98.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.82 -41.31 83.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -42.19 98.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -61.1 -40.34 93.38 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -45.61 66.76 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -65.94 -46.91 76.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.125 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 34.6 mmt -62.28 -29.98 70.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -43.98 69.17 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.969 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 -53.74 53.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.239 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -32.39 72.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.15 77.81 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.238 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.8 t -61.62 -45.52 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.574 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.41 -128.26 43.45 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.47 -27.26 84.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.706 2.271 . . . . 0.0 112.462 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 t -96.64 22.81 7.6 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.812 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -86.45 -40.2 15.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.606 0.241 . . . . 0.0 110.644 179.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.76 -48.0 0.89 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.43 160.25 29.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.608 0.242 . . . . 0.0 111.021 179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.08 160.98 44.78 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.65 2.233 . . . . 0.0 112.528 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.2 Cg_endo -68.42 129.56 19.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.851 2.367 . . . . 0.0 112.675 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.2 Cg_endo -85.43 54.75 3.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.022 2.482 . . . . 0.0 112.331 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.059 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 m80 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -74.42 1.28 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.555 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.0 152.09 23.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.11 -107.16 0.66 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.509 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -128.08 74.35 1.54 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.52 -29.57 18.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.461 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -56.73 -34.18 67.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.534 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -58.02 -43.69 86.88 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.76 179.561 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -31.18 64.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.354 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -46.7 88.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 -41.62 93.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -69.54 -44.1 71.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.106 179.739 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -63.61 -41.31 98.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.484 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -49.12 76.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.991 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.45 -39.74 74.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.691 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 2.1 tt0 -58.96 -36.0 74.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.523 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.04 -45.51 86.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.341 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.57 65.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.5 -42.32 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.491 179.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.478 ' HA ' ' CG ' ' A' ' 38' ' ' PRO . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.38 -132.24 41.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.23 -30.76 74.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.893 2.395 . . . . 0.0 112.762 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 p -93.33 41.49 1.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.621 -179.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -115.29 -33.7 5.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.247 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.11 -44.82 1.0 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.61 157.28 36.2 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.61 0.243 . . . . 0.0 111.504 -179.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.57 169.53 19.73 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.768 2.312 . . . . 0.0 112.441 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 25' ' ' TRP . 36.7 Cg_endo -65.2 144.39 81.04 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.643 2.229 . . . . 0.0 112.838 -179.947 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' CG ' ' HA ' ' A' ' 22' ' ' PHE . 52.2 Cg_endo -69.75 154.96 67.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.0 2.466 . . . . 0.0 112.655 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.944 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 -41.41 1.63 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.6 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.15 79.54 0.25 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 -77.12 1.31 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.375 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -107.47 49.18 0.81 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.544 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -93.54 7.8 43.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.743 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -109.45 -35.62 6.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.579 0.228 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 t -91.75 -45.24 8.53 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.31 -44.79 64.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.235 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.15 -45.48 93.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.752 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.2 p -61.47 -36.83 81.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.59 -43.92 79.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.982 179.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -70.1 -45.08 67.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.027 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -45.72 90.72 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.08 -38.42 85.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.12 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.73 -40.21 75.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.177 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.56 -40.88 88.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.611 179.466 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.4 t -60.41 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.756 179.687 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.604 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.92 -127.68 44.74 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.41 -29.32 89.84 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.754 2.303 . . . . 0.0 112.56 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -98.92 38.49 1.37 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.601 -179.936 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -101.81 -38.82 7.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.816 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.32 -50.14 0.67 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.82 163.49 17.96 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.067 179.699 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 163.25 39.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.575 2.184 . . . . 0.0 112.398 179.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 38.2 Cg_endo -66.54 125.31 13.67 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.594 2.196 . . . . 0.0 112.565 -179.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.8 Cg_endo -73.08 106.05 2.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.827 2.351 . . . . 0.0 112.114 179.859 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.703 -179.514 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.4 t60 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.31 -123.02 2.48 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.54 56.1 1.86 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.074 0.464 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 55.93 0.02 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.755 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -132.64 25.86 4.38 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.719 0.295 . . . . 0.0 111.238 179.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.81 -25.83 22.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.591 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 t -57.58 -37.07 72.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.563 0.22 . . . . 0.0 111.168 179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -89.5 -39.44 13.33 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.073 179.567 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.08 -41.26 99.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 7.9 tp -63.02 -38.5 91.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.001 179.754 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -61.68 -36.55 81.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.045 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -71.87 -48.85 42.95 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.302 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' HG2' ' HA ' ' A' ' 10' ' ' LEU . 13.3 pt20 -66.29 -33.27 75.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.1 mmm -70.14 -35.8 74.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.569 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 -47.83 34.58 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.573 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 12.6 pt-20 -58.95 -35.69 73.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -39.73 80.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.794 179.402 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.37 79.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.044 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.39 -45.03 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.73 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.502 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 26' ' ' LEU . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.28 32.62 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.13 -25.41 72.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.815 2.343 . . . . 0.0 112.781 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -93.85 34.97 1.17 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 111.649 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -112.61 -32.03 6.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.116 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.67 -44.13 1.31 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.699 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.74 151.76 50.53 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.303 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 160.61 48.92 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.75 2.3 . . . . 0.0 112.541 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -70.27 130.31 18.5 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.788 2.325 . . . . 0.0 112.654 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.0 Cg_endo -73.11 109.29 2.8 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.766 2.311 . . . . 0.0 112.401 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.136 -179.961 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.49 0.186 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.79 -58.1 1.13 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 68.56 155.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.959 0.409 . . . . 0.0 111.495 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.3 65.31 2.28 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.2 p -123.97 -120.53 0.27 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.688 0.28 . . . . 0.0 110.481 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -79.69 -29.41 40.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.378 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -59.88 -38.78 83.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.59 -179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 p -64.1 -42.65 96.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.174 179.844 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -37.05 69.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -35.79 80.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.005 179.75 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 m -60.16 -42.84 95.78 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -34.07 62.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.599 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -67.62 -31.97 72.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.28 179.734 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.8 mtp -77.27 -31.46 54.93 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -79.25 -40.13 31.36 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.392 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.55 -35.48 76.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 -179.746 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -71.38 -38.45 71.53 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.696 0.284 . . . . 0.0 110.813 179.512 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.92 89.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.4 t -64.97 -44.7 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.487 179.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.507 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.527 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -131.21 45.32 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.17 -35.22 42.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -70.67 -21.09 62.63 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.93 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -64.02 -26.49 68.59 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.63 37.6 4.44 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.72 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.86 147.22 15.95 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 110.739 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.62 155.35 70.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.382 2.054 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.97 136.19 26.88 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.886 2.391 . . . . 0.0 112.609 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -66.92 -44.53 5.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.907 2.405 . . . . 0.0 112.389 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 6.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.059 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.39 101.85 0.24 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.26 121.55 19.2 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.665 0.269 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.85 7.1 45.19 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.438 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 t 38.73 66.56 0.51 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.17 0.509 . . . . 0.0 111.88 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.35 -32.94 69.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.598 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -59.65 -49.52 77.44 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -38.86 81.2 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -40.1 95.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.275 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -40.12 94.91 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -62.84 -45.09 94.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.046 179.653 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -40.18 94.08 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -66.15 -46.16 78.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mtt -62.43 -45.09 94.66 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.933 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.65 -35.0 79.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.786 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.95 -38.91 73.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.415 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -45.25 93.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.221 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.85 -38.94 92.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.9 -39.81 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.487 179.23 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.06 -131.54 30.6 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.27 -27.79 72.25 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 112.869 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.51 26.83 3.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -103.35 -32.1 9.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.381 0.134 . . . . 0.0 111.106 179.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.5 -46.28 1.09 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.34 154.19 46.57 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.814 0.34 . . . . 0.0 111.381 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.2 164.18 36.43 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.834 2.356 . . . . 0.0 112.534 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.04 136.53 38.25 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.64 2.227 . . . . 0.0 112.629 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.91 139.16 35.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.901 2.401 . . . . 0.0 112.577 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.436 -0.793 . . . . 0.0 110.905 179.873 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.47 171.29 33.31 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.717 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -178.25 6.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.618 0.246 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.03 30.84 4.03 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.831 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -152.08 91.07 1.58 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.477 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' O ' ' HB ' ' A' ' 7' ' ' THR . 89.3 m-85 -117.13 -49.91 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.676 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.4 m 75.96 -55.88 0.6 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.743 0.652 . . . . 0.0 111.276 -179.437 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 p -84.75 -43.79 13.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.18 -37.37 57.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.86 94.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -60.53 -39.72 88.9 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.013 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -67.53 -42.68 82.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -63.08 -40.7 98.44 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.0 mtp -58.3 -45.83 87.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.63 -36.09 65.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.0 -42.02 84.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -59.68 -39.9 86.07 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.748 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.32 -37.48 87.23 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.78 -47.54 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.557 179.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.18 -133.58 12.27 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.42 -31.63 95.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.69 2.26 . . . . 0.0 112.656 179.818 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.23 33.7 3.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.711 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 t -97.53 -38.64 9.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.545 0.212 . . . . 0.0 110.952 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.39 -53.33 0.54 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.505 -179.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.75 158.26 32.77 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.578 0.228 . . . . 0.0 111.122 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.1 165.36 30.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.719 2.279 . . . . 0.0 112.661 -179.901 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.01 132.97 33.87 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.624 2.216 . . . . 0.0 112.393 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 52.3 Cg_endo -69.59 151.09 69.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.861 2.374 . . . . 0.0 112.621 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.392 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 23' ' ' ILE . 40.3 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.512 0.196 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 19' ' ' VAL . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.496 0.189 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 23' ' ' ILE . 16.2 t . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.495 0.188 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' HG12 ' A' ' 19' ' ' VAL . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.641 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 23' ' ' ILE . 63.9 t . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.501 ' CD1' HG12 ' A' ' 19' ' ' VAL . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.7 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 23' ' ' ILE . 39.2 t . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 19' ' ' VAL . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.59 0.233 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.499 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 23' ' ' ILE . 19.9 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.618 0.246 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.54 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 23' ' ' ILE . 94.6 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.488 0.185 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.718 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 19' ' ' VAL . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 23' ' ' ILE . 31.8 t . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.7 0.286 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 19' ' ' VAL . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.631 0.253 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 23' ' ' ILE . 25.1 t . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 19' ' ' VAL . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 23' ' ' ILE . 57.5 t . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.612 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 19' ' ' VAL . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.454 0.168 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 23' ' ' ILE . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 20' ' ' ARG . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.53 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.508 HG12 ' CD1' ' A' ' 23' ' ' ILE . 22.5 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.671 0.272 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 23' ' ' ILE . 46.8 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.462 0.172 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 19' ' ' VAL . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.635 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.4 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.465 0.174 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.658 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 19' ' ' VAL . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 23' ' ' ILE . 67.7 t . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.543 0.211 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 23' ' ' ILE . 35.6 t . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 23' ' ' ILE . 21.8 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.576 0.227 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 19' ' ' VAL . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.613 0.244 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 23' ' ' ILE . 46.6 t . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.589 0.233 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.51 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.616 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 23' ' ' ILE . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' A' ' 23' ' ' ILE . 59.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.501 0.191 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.5 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 23' ' ' ILE . 59.0 t . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.528 0.204 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 23' ' ' ILE . 43.9 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.571 0.224 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 HD11 ' A' ' 23' ' ' ILE . 48.1 t . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.606 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.48 0.181 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.8 t . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.504 0.192 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 19' ' ' VAL . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 23' ' ' ILE . 61.8 t . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.553 0.216 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 23' ' ' ILE . 32.4 t . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.378 0.132 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 23' ' ' ILE . 78.1 t . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.586 0.232 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 23' ' ' ILE . 92.4 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.503 0.192 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 19' ' ' VAL . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.539 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 23' ' ' ILE . 48.6 t . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.561 0.22 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.504 ' CD1' HG12 ' A' ' 19' ' ' VAL . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.507 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.614 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.507 0.194 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.534 0.207 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.98 -92.95 0.1 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.641 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.6 152.46 20.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.04 70.48 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -94.19 61.07 2.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.085 0.469 . . . . 0.0 110.651 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -109.38 -32.64 7.09 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.442 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -58.33 -36.01 72.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -57.73 -47.22 83.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.29 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.64 -34.54 53.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -40.84 95.42 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.236 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -43.69 90.3 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.089 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -69.48 -44.87 70.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.707 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -55.32 -38.51 68.81 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.99 -44.42 87.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.716 0.294 . . . . 0.0 110.81 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -38.5 88.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -37.81 88.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.226 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -60.89 -40.87 94.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.02 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.57 81.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 23' ' ' ILE . 40.3 t -62.92 -42.71 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 19' ' ' VAL . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.24 -132.71 25.75 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.03 -35.03 89.33 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.986 2.458 . . . . 0.0 112.748 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -95.24 44.5 1.09 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 t -116.57 -34.64 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.272 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.28 -42.0 1.48 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.504 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.22 40.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 111.2 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 162.71 41.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.784 2.323 . . . . 0.0 112.579 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.8 Cg_endo -70.21 139.1 37.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.796 2.331 . . . . 0.0 112.64 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 71.0 Cg_endo -74.85 90.34 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.84 2.36 . . . . 0.0 112.27 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.151 -179.884 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.517 0.199 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.82 64.49 0.56 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.09 136.0 48.5 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.09 -101.85 0.53 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -149.34 62.3 1.03 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.741 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.27 12.74 8.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.121 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -81.62 -51.33 8.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -68.45 -35.93 78.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.22 -40.25 71.23 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.305 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -61.2 -35.8 78.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -62.71 -42.95 99.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.82 -34.66 39.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.254 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -69.08 -47.65 64.69 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.363 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.1 -40.31 89.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 19' ' ' VAL . 6.9 mm-40 -69.97 -43.28 71.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.258 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.5 -46.92 71.5 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -61.53 -37.01 82.19 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.087 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.76 92.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.146 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 15' ' ' GLU . 82.1 t -64.57 -44.92 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.576 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 38' ' ' PRO . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.82 -130.69 17.59 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.01 -26.88 73.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.986 2.458 . . . . 0.0 112.818 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.75 46.3 1.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.289 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -136.37 11.13 3.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.0 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.36 35.59 92.27 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.675 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.05 137.34 9.96 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 120.651 0.262 . . . . 0.0 111.257 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.66 157.71 60.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.695 2.263 . . . . 0.0 112.702 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 61.3 Cg_endo -72.32 141.62 35.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.735 2.29 . . . . 0.0 112.396 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HB2' HD23 ' A' ' 21' ' ' LEU . 37.5 Cg_endo -65.52 -36.18 35.21 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.694 2.263 . . . . 0.0 112.403 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.928 179.763 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.67 0.271 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.17 119.6 2.55 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.83 144.37 30.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.705 0.288 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -53.27 0.59 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 t -115.56 67.7 0.71 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.181 0.515 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -98.87 -29.05 13.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.37 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -63.4 -25.63 68.37 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.764 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -57.69 -52.4 65.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.734 0.302 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.05 -35.04 43.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.962 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.98 -39.12 91.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.215 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -61.03 -40.43 93.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.247 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.79 -43.91 97.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.307 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -73.67 -42.3 61.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.177 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.1 90.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.025 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.35 -44.99 95.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.34 -41.83 90.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.21 -40.33 95.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.79 87.81 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.346 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 15' ' ' GLU . 16.2 t -61.05 -38.43 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' HG12 ' A' ' 19' ' ' VAL . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.57 -135.59 19.65 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.6 -33.05 93.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.897 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.26 41.39 1.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.732 0.301 . . . . 0.0 111.685 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -113.12 -34.73 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.52 -47.54 0.97 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.713 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.82 40.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.291 . . . . 0.0 111.254 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 165.19 32.05 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.765 2.31 . . . . 0.0 112.569 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.9 Cg_endo -68.32 153.03 75.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.758 2.305 . . . . 0.0 112.722 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 86.7 Cg_endo -89.14 43.68 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.247 2.632 . . . . 0.0 112.644 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.063 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.1 p80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.19 178.45 43.58 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.2 156.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 111.42 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.8 62.76 0.93 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.475 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -94.93 39.63 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.345 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 -33.82 26.07 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.245 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -61.27 -35.2 76.66 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.454 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -77.1 -36.23 55.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.668 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.52 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.644 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -40.6 88.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -62.65 -33.28 74.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.927 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -40.99 96.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.968 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -67.01 -47.79 70.38 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 7.0 mtt -63.72 -40.11 95.95 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.663 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 mm-40 -64.88 -38.77 92.1 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.77 -40.85 76.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.065 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.24 -39.52 94.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.854 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.67 94.65 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.123 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 15' ' ' GLU . 44.9 t -64.81 -45.47 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.252 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.11 -133.74 13.36 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.17 -31.18 94.89 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.74 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 t -101.8 32.91 3.2 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.4 t -97.32 -38.48 9.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.502 0.191 . . . . 0.0 110.911 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.47 -60.45 0.42 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.523 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -93.84 163.37 24.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 56.6 Cg_endo -70.52 164.4 35.44 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.6 Cg_endo -68.12 125.86 13.61 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.586 2.191 . . . . 0.0 112.756 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.2 Cg_endo -78.03 121.87 5.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.885 2.39 . . . . 0.0 112.392 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.143 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.517 0.198 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.35 -59.57 0.56 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.78 87.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.18 2.83 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.42 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -120.44 45.06 2.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -16.01 43.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.872 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -54.77 -39.65 68.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.672 0.272 . . . . 0.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 m -90.26 -34.78 15.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.105 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -61.89 -42.79 99.49 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -46.21 90.09 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -61.96 -41.32 97.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.124 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -70.46 -39.13 74.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.224 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -58.43 -42.57 87.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.057 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.11 -42.11 76.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.93 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -33.47 71.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.341 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -56.32 -36.28 68.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.541 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.93 -46.19 90.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 111.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -43.89 90.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 23' ' ' ILE . 63.9 t -62.08 -38.65 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.501 ' CD1' HG12 ' A' ' 19' ' ' VAL . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.7 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.74 -129.59 48.65 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.73 -34.18 63.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.767 2.312 . . . . 0.0 112.564 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -27.51 69.13 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.83 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -56.18 -35.81 67.65 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.87 -47.35 1.02 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.52 151.72 59.33 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.588 0.232 . . . . 0.0 111.383 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.55 163.32 37.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.722 2.282 . . . . 0.0 112.243 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' HB3' ' CZ3' ' A' ' 25' ' ' TRP . 38.5 Cg_endo -66.31 146.6 81.35 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.556 2.171 . . . . 0.0 112.817 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HB3' HD23 ' A' ' 21' ' ' LEU . 48.4 Cg_endo -68.71 159.14 54.91 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.021 2.48 . . . . 0.0 112.712 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.226 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.47 0.176 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.93 44.08 1.58 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.697 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -149.66 87.73 1.51 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.45 58.04 0.41 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.525 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -142.13 85.21 1.91 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.511 ' O ' ' HB ' ' A' ' 7' ' ' THR . 21.6 m-85 -106.14 -62.99 1.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.024 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.3 m 73.53 -57.94 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.405 0.682 . . . . 0.0 111.098 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 m -94.22 -40.16 10.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.812 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -70.09 -32.99 71.31 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.022 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -63.67 -41.15 98.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 m -62.53 -42.87 99.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.995 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.84 -43.16 76.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.3 93.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.1 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.0 mtt -59.69 -41.17 90.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.85 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 5.2 mm-40 -61.99 -38.47 88.74 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.712 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.2 -37.38 82.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.005 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.01 -44.5 82.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.91 90.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' GLU . 39.2 t -61.62 -39.77 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 19' ' ' VAL . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 -130.32 9.72 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.86 -24.65 79.66 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.842 2.361 . . . . 0.0 112.805 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -98.49 34.51 2.0 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -99.29 -35.06 10.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.059 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.92 -42.95 1.24 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -109.37 158.0 35.73 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 36.7 Cg_endo -65.68 163.8 29.03 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.73 2.287 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.7 Cg_endo -66.27 134.62 36.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.71 2.273 . . . . 0.0 112.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 73.9 Cg_endo -75.23 155.63 41.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.921 2.414 . . . . 0.0 112.521 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.219 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.13 94.29 0.7 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.496 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.04 95.52 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.87 57.39 4.07 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.531 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.6 t -141.64 49.02 1.61 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.226 0.536 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.95 11.76 17.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.946 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -104.26 -39.68 6.4 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.527 0.203 . . . . 0.0 111.075 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.6 p -68.37 -50.0 56.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.528 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -67.85 -42.56 81.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.466 HD23 ' HG3' ' A' ' 14' ' ' MET . 0.2 OUTLIER -63.88 -32.56 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -37.92 85.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.069 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -62.58 -51.21 68.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.118 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -69.73 -38.56 76.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.448 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.466 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -63.03 -38.06 89.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.048 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 5.1 mm-40 -60.85 -43.79 97.85 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.821 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.49 -44.4 62.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.792 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.06 -39.69 90.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.108 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.93 94.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 15' ' ' GLU . 64.0 t -64.32 -43.54 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.381 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.499 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.79 26.45 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -30.93 79.2 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.908 2.406 . . . . 0.0 112.673 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 p -95.0 33.22 1.54 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -108.57 -32.87 7.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.196 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.74 -47.07 1.03 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.778 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.76 154.12 42.17 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.701 0.286 . . . . 0.0 111.196 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.86 164.0 36.81 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.805 2.336 . . . . 0.0 112.642 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.12 134.97 33.21 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.708 2.272 . . . . 0.0 112.705 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.7 Cg_endo -72.76 94.69 0.79 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.929 2.419 . . . . 0.0 112.224 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.188 -179.802 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.88 -113.88 2.18 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.643 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.74 139.54 37.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.28 80.55 0.2 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.912 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.51 32.73 18.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.851 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER 61.09 17.44 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.909 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -107.14 -42.98 4.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.13 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -37.68 88.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.88 -39.7 23.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.313 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -63.62 -39.42 94.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.232 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.1 p -60.99 -37.6 83.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.033 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -63.58 -43.84 95.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.837 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -69.65 -41.23 75.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.2 mmt -58.16 -47.23 84.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.6 mm-40 -63.85 -38.13 89.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -40.22 84.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.333 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -59.58 -42.27 92.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.207 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.06 93.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 15' ' ' GLU . 19.9 t -63.82 -41.53 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.498 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.54 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.77 -132.06 28.99 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.42 -30.11 79.96 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.951 2.434 . . . . 0.0 112.842 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -99.5 39.51 1.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -112.25 -32.93 6.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.44 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.53 -46.04 1.06 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.633 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.44 154.88 37.38 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.374 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.14 166.82 27.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.879 2.386 . . . . 0.0 112.551 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.11 146.09 75.42 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.74 2.293 . . . . 0.0 112.9 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 84.1 Cg_endo -76.66 -17.81 15.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.097 2.531 . . . . 0.0 113.161 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.2 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.57 -163.0 36.79 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.764 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.96 153.83 49.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.47 71.25 0.33 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.362 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m 63.62 78.57 0.29 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 10' ' ' LEU . 37.2 p90 -77.28 -27.24 53.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.429 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -53.45 -34.09 56.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.575 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -57.82 -46.32 84.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.67 0.272 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.24 -32.7 63.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.988 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.577 HD23 ' HD1' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -59.96 -43.56 94.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.309 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -45.84 92.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -67.57 -40.24 84.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -64.16 -45.23 89.32 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -40.22 83.36 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 19' ' ' VAL . 27.6 mt-10 -70.32 -47.0 63.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.055 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -46.06 87.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.194 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -61.88 -38.62 88.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.815 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.48 94.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 15' ' ' GLU . 94.6 t -63.11 -44.94 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.718 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 19' ' ' VAL . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.461 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 -133.33 20.86 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.81 -32.22 95.12 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.714 2.276 . . . . 0.0 112.593 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -98.27 26.17 5.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.1 t -88.97 -39.18 13.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 110.901 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 149.6 -46.85 0.64 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.633 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -109.49 164.09 15.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.655 0.264 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 55.5 Cg_endo -70.4 164.53 34.85 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.715 2.277 . . . . 0.0 112.5 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.8 Cg_endo -65.96 134.44 37.19 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.731 2.287 . . . . 0.0 112.44 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.4 Cg_endo -71.67 101.72 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.792 2.328 . . . . 0.0 112.177 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.227 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.3 p80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.739 0.305 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.9 125.7 3.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.595 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.18 169.51 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.802 0.334 . . . . 0.0 111.278 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.19 85.14 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.78 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -105.34 35.81 2.71 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.127 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -71.55 -31.73 67.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.066 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -94.71 -24.38 17.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.435 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -80.95 -54.12 5.85 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -43.24 98.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.734 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -62.13 -35.29 78.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.138 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -62.55 -42.84 99.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.708 0.29 . . . . 0.0 110.884 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -72.28 -43.79 63.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -39.52 91.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.142 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.69 -40.46 92.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 mm-40 -64.6 -35.41 80.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.022 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -39.82 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.024 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.78 -41.05 94.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.822 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.29 95.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 23' ' ' ILE . 31.8 t -63.61 -44.17 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 19' ' ' VAL . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.12 -135.56 22.86 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.48 -30.97 80.57 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.718 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -95.88 30.94 2.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -106.37 -32.84 7.96 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.213 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.51 -45.12 1.17 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.94 45.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 120.55 0.214 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.56 162.85 40.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.69 2.26 . . . . 0.0 112.639 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 25' ' ' TRP . 53.8 Cg_endo -69.84 144.53 53.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.622 2.215 . . . . 0.0 112.68 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' PHE . 27.3 Cg_endo -62.24 -41.5 34.3 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.835 2.357 . . . . 0.0 112.376 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.902 179.794 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.57 0.224 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.69 -102.36 1.77 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.573 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.86 158.91 43.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.13 -106.7 0.88 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.588 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 5' ' ' THR . 4.8 t -151.58 89.73 1.51 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.141 0.496 . . . . 0.0 110.699 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -9.93 56.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.003 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -55.25 -45.72 76.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.683 0.278 . . . . 0.0 111.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -88.97 -33.1 17.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.251 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -63.56 -37.08 85.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.799 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -43.97 95.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.345 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -61.05 -40.58 94.16 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.636 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -40.37 62.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -50.53 70.52 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.63 -39.34 87.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.8 tt0 -64.93 -41.84 95.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.13 -46.32 90.04 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.468 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -38.44 87.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.681 0.276 . . . . 0.0 110.935 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 21' ' ' LEU . . . -62.33 -41.21 98.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.22 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 28.7 t -63.05 -42.47 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.542 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 18' ' ' ALA . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.83 -128.07 39.8 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.5 -30.5 90.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.676 2.25 . . . . 0.0 112.568 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -96.21 33.71 1.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 t -96.21 -39.03 9.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.908 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.83 -46.28 0.71 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.619 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -113.41 164.0 16.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.951 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.7 Cg_endo -66.87 165.14 26.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.654 2.236 . . . . 0.0 112.541 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -65.82 130.71 25.34 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.8 2.333 . . . . 0.0 112.6 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.3 Cg_endo -73.62 142.44 32.57 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.839 2.359 . . . . 0.0 112.324 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.444 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.894 0.378 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 64.57 0.04 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.578 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.08 156.2 20.86 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.793 0.33 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.73 -86.16 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.466 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 m 70.87 104.12 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.242 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.39 11.12 7.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.504 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -96.25 -55.21 3.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.71 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.5 t -77.58 -39.18 46.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.861 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.3 -44.15 95.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -38.82 92.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.695 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -61.78 -40.04 93.8 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.786 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -41.33 99.52 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.739 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -62.16 -47.2 85.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -39.04 93.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -64.08 -37.38 87.24 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.047 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.99 -39.41 94.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.8 92.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' GLU . 25.1 t -62.42 -43.16 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 19' ' ' VAL . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.27 -129.66 31.72 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.58 -29.53 70.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.719 2.279 . . . . 0.0 112.782 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -92.5 33.93 1.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -111.23 -29.11 7.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.471 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.45 33.95 2.19 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.682 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.63 148.27 3.28 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.52 0.2 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.41 159.76 52.43 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.514 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.73 140.43 46.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.683 2.255 . . . . 0.0 112.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.9 Cg_endo -71.18 117.41 5.14 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.847 2.365 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.474 0.178 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.72 -124.14 2.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.658 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -152.37 146.39 25.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.929 0.395 . . . . 0.0 111.323 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 10.87 83.11 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.206 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.8 p -113.93 51.44 0.87 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.021 0.438 . . . . 0.0 110.592 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 7' ' ' THR . 12.7 m-85 -120.84 -60.97 1.61 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.948 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 71.1 m 74.19 -55.82 0.65 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.246 0.618 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -80.48 -41.99 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 26.4 t70 -63.68 -44.17 94.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.179 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -62.04 -38.56 89.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m -61.56 -39.16 90.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.075 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -48.3 60.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -60.58 -36.4 78.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.0 mmt -57.58 -39.15 76.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.229 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.6 mm-40 -62.48 -47.02 85.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.221 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.16 -45.5 93.16 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.29 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.7 -38.41 84.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.05 91.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.348 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.5 t -63.08 -41.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.464 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.612 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 19' ' ' VAL . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.521 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.52 -132.79 27.49 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.14 -31.57 83.03 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.931 2.421 . . . . 0.0 112.711 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 m -96.39 40.94 1.12 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 111.73 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -114.53 -33.88 5.41 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.236 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.65 -46.62 1.05 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.801 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.09 154.96 45.09 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 111.3 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.39 162.67 40.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.844 2.363 . . . . 0.0 112.678 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 57.0 Cg_endo -70.49 128.86 15.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.762 2.308 . . . . 0.0 112.674 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 68.7 Cg_endo -75.98 101.32 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.822 2.348 . . . . 0.0 112.517 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.127 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.734 0.302 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.19 140.4 7.46 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.438 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.32 133.89 11.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.669 0.271 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.85 84.19 0.19 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.624 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t 42.32 46.19 3.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -42.71 8.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.709 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -65.26 -44.36 88.34 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -63.36 -39.16 93.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.966 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -41.19 69.31 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.188 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.46 -43.72 98.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.078 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 t -63.58 -40.99 98.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -71.46 -40.47 70.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.48 -45.97 92.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.1 mtp -57.07 -46.07 82.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.22 -44.01 85.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.94 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.85 88.63 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -39.75 92.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.813 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.13 89.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.71 -42.34 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 23' ' ' ILE . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 20' ' ' ARG . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.53 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -131.02 30.18 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.12 -27.03 73.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.938 2.425 . . . . 0.0 112.905 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -95.47 21.23 8.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -96.89 -33.04 11.76 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.464 0.173 . . . . 0.0 111.108 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.88 -51.39 0.86 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.6 60.01 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.0 162.22 43.03 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.697 2.265 . . . . 0.0 112.628 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.6 Cg_endo -69.02 138.05 39.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.684 2.256 . . . . 0.0 112.56 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 57.1 Cg_endo -71.33 118.96 5.94 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.846 2.364 . . . . 0.0 112.623 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.688 0.28 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.07 -141.45 3.13 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.687 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.19 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 111.427 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.81 -52.66 0.76 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.637 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -130.9 40.61 3.46 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.1 -28.45 16.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.387 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -56.19 -36.18 68.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.663 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -44.47 92.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.83 -37.8 34.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -42.49 98.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.213 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -62.72 -42.64 99.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -68.96 -42.72 76.27 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.9 -40.02 95.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -61.35 -39.95 92.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.2 mt-10 -62.54 -41.56 98.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.24 -40.41 81.67 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.11 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.1 -41.33 92.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.143 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.94 97.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.977 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.508 HG12 ' CD1' ' A' ' 23' ' ' ILE . 22.5 t -62.72 -40.85 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.442 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.69 -132.13 24.31 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.79 -35.73 66.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.965 2.443 . . . . 0.0 112.534 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -94.99 42.46 1.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 111.716 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 t -116.31 -33.19 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.22 36.08 1.69 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.424 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.45 145.82 4.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.561 0.219 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.51 156.77 64.74 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.596 2.198 . . . . 0.0 112.682 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 59.5 Cg_endo -70.83 142.84 44.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.859 2.372 . . . . 0.0 112.435 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 57.8 Cg_endo -71.46 104.89 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.772 2.315 . . . . 0.0 112.364 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.032 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.832 0.348 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.59 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 62.57 89.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 111.275 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.26 69.5 0.05 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.678 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -116.46 50.97 1.01 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.123 0.487 . . . . 0.0 110.838 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -162.0 79.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.13 0.967 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -111.29 -40.9 4.28 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 p -69.02 -44.73 72.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.149 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.28 87.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.11 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.04 -45.94 89.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -63.04 -38.75 92.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -67.31 -40.16 85.99 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.429 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 46.7 mt-30 -65.75 -33.25 75.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.265 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 46.6 mtp -68.24 -33.23 74.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.686 0.279 . . . . 0.0 110.832 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.4 mt-10 -72.71 -47.15 49.53 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.821 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.0 -35.61 75.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.366 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -36.41 67.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.895 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.8 -35.99 79.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.048 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 15' ' ' GLU . 46.8 t -62.11 -43.77 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.668 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 19' ' ' VAL . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.513 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.635 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.23 -130.26 35.09 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.13 -28.96 80.35 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.865 2.377 . . . . 0.0 112.703 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -97.13 40.82 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.673 0.273 . . . . 0.0 111.708 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -114.2 -33.86 5.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.21 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.07 -47.58 0.96 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.705 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.94 154.07 37.52 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.668 0.271 . . . . 0.0 111.304 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.59 168.36 20.09 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.9 153.59 77.33 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.67 2.247 . . . . 0.0 112.8 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 89.4 Cg_endo -81.98 -1.33 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.148 2.565 . . . . 0.0 113.491 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.713 -0.661 . . . . 0.0 111.448 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.615 0.245 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.44 0.24 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.523 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.36 119.79 22.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.25 56.28 0.1 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.455 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 p -138.89 46.9 1.95 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.723 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.07 -32.42 63.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.625 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -61.68 -48.44 80.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.2 p -65.47 -40.36 93.06 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -36.12 80.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.23 -39.19 93.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.924 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -60.69 -44.39 96.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.087 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -75.71 -37.04 59.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.252 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.47 -43.6 98.58 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.19 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mtt -59.3 -45.78 90.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.964 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.24 -42.93 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.12 -42.1 98.89 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -38.83 87.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.039 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.03 88.59 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t -61.04 -52.08 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.452 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 -131.84 31.95 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.86 -31.88 77.55 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.919 2.413 . . . . 0.0 112.755 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -96.29 40.95 1.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.712 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 t -113.34 -31.26 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.22 32.78 2.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.605 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.42 148.06 4.05 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.618 0.247 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.64 158.33 58.17 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.598 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -69.17 138.29 39.31 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.764 2.309 . . . . 0.0 112.252 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 49.2 Cg_endo -69.04 109.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.738 2.292 . . . . 0.0 112.498 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.037 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.66 -137.11 12.61 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.677 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -130.4 143.53 50.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.71 49.23 1.11 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.73 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m 59.34 86.74 0.09 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.272 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -66.41 -31.23 71.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -60.65 -34.24 73.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.353 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -56.71 -48.2 78.24 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.057 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.7 -36.88 62.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.064 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -38.82 82.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -47.4 85.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -70.41 -40.91 73.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -57.88 -43.07 85.82 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -42.69 93.45 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.73 -39.68 88.07 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -43.23 96.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.995 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -39.27 91.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.981 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.32 83.71 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.113 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.4 t -62.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.658 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 19' ' ' VAL . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.92 -126.45 38.84 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.05 -31.72 93.82 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.646 2.231 . . . . 0.0 112.423 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.36 50.76 1.26 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 m -112.61 -39.39 4.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.53 -40.11 1.24 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.4 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -115.96 161.65 29.79 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 47.7 Cg_endo -68.33 165.15 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 29.5 Cg_endo -63.2 132.3 35.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.65 2.233 . . . . 0.0 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' CB ' HD23 ' A' ' 21' ' ' LEU . 56.1 Cg_endo -70.54 134.15 25.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.803 2.336 . . . . 0.0 112.593 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.904 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.4 m80 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.515 0.197 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.61 62.32 0.43 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.58 137.12 33.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 111.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.65 -53.99 2.31 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.551 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 62.09 32.11 17.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.714 0.292 . . . . 0.0 111.245 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.74 15.56 5.96 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -103.94 -51.91 3.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.252 . . . . 0.0 111.117 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p -65.72 -40.12 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.22 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.12 -41.59 77.17 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.03 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.57 98.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -42.0 98.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.736 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.09 89.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -67.31 -38.52 85.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mtt -60.36 -40.15 89.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.884 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.65 -41.2 94.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.98 -40.32 97.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.805 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.72 -39.22 87.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.784 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 21' ' ' LEU . . . -60.14 -38.32 82.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 23' ' ' ILE . 67.7 t -62.46 -45.3 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 18' ' ' ALA . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.02 -132.6 11.22 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.05 -30.19 90.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.829 2.353 . . . . 0.0 112.684 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -100.84 41.25 1.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.727 0.298 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.1 -35.63 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.294 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.31 -52.85 0.59 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.572 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -102.04 159.09 30.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.6 Cg_endo -67.13 163.88 32.38 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -64.92 128.46 20.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.71 2.273 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 63.6 Cg_endo -74.06 145.97 36.16 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.86 2.374 . . . . 0.0 112.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.002 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.718 0.294 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.64 90.49 2.03 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.442 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 155.26 49.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.18 -43.74 1.34 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.7 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -119.35 73.23 0.94 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.051 0.453 . . . . 0.0 110.785 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.643 ' HD2' HD23 ' A' ' 10' ' ' LEU . 43.3 m-85 -68.55 -51.31 44.24 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.742 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 98.7 m 74.01 -55.5 0.66 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.5 p -78.55 -47.98 16.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.471 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.19 -41.03 43.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.368 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -61.86 -38.37 88.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -63.92 -43.7 95.13 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.243 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.68 -40.13 76.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.46 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -68.55 -44.0 75.45 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.482 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.33 -44.46 95.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.311 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . 23.0 mm-40 -67.39 -41.03 85.64 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.42 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.26 -41.81 80.54 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.456 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.63 -40.73 95.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.155 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.31 86.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 15' ' ' GLU . 35.6 t -62.52 -41.17 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.585 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.09 -128.6 25.72 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.78 -28.55 86.64 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.641 2.228 . . . . 0.0 112.559 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -98.73 24.02 8.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -86.58 -26.62 24.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.374 0.131 . . . . 0.0 111.087 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.31 31.07 2.71 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.846 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -176.65 156.36 1.39 Allowed Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.593 0.235 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.4 Cg_endo -67.71 157.74 60.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.484 2.122 . . . . 0.0 112.303 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 48.3 Cg_endo -67.97 134.02 30.78 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.6 Cg_endo -74.73 84.14 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.758 2.305 . . . . 0.0 112.28 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.086 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 p80 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.11 176.89 39.04 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.45 96.07 2.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.69 -44.74 7.13 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.617 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.44 71.72 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.091 0.472 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -122.93 12.06 9.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.846 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -101.25 -50.21 3.84 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 110.723 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.7 t -83.04 -40.7 19.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.212 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.96 -46.89 79.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -41.09 94.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -62.89 -44.79 95.16 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -69.21 -36.54 77.38 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.162 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -49.99 75.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 mtt -58.6 -39.48 80.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.913 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 mt-10 -66.35 -45.69 79.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.967 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.69 -45.87 90.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.209 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.08 -36.82 82.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.23 90.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 15' ' ' GLU . 21.8 t -60.86 -42.88 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.742 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 19' ' ' VAL . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.74 -132.37 34.59 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.4 -31.78 81.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.945 2.43 . . . . 0.0 112.639 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.84 38.72 1.16 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.69 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 t -111.81 -33.64 6.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.213 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.15 1.24 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.608 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.96 153.36 41.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 111.265 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.72 163.74 37.95 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.823 2.349 . . . . 0.0 112.49 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.21 142.42 55.43 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.686 2.257 . . . . 0.0 112.593 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 73.6 Cg_endo -76.14 169.88 21.17 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.955 2.437 . . . . 0.0 112.626 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.965 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.731 0.3 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.89 -105.0 2.49 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 55.55 61.33 2.89 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.97 -45.47 1.0 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.722 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m 60.36 50.43 6.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' HD1' HD12 ' A' ' 10' ' ' LEU . 54.1 p90 -89.52 -30.76 18.01 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 m -60.28 -40.22 89.62 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.481 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.091 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.6 -36.58 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.276 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' HD1' ' A' ' 6' ' ' PHE . 5.8 mt -60.86 -40.19 91.97 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.304 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -60.39 -44.24 95.86 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -40.96 66.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -50.63 72.69 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 mtm -57.06 -41.53 78.93 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.01 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.51 -37.4 85.88 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.949 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.38 76.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.31 -40.94 97.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.836 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.65 88.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.27 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.21 -46.84 89.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.577 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.35 -129.59 45.64 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.08 -27.56 84.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.838 2.359 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -94.92 42.65 1.09 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.725 0.298 . . . . 0.0 111.555 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -115.82 -34.59 4.75 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.14 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.65 -43.1 1.34 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.623 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.1 153.91 39.0 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 111.36 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.69 165.22 30.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.784 2.323 . . . . 0.0 112.627 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 138.67 43.39 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.715 2.277 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 55.8 Cg_endo -70.65 131.14 19.41 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.894 2.396 . . . . 0.0 112.402 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.759 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 m170 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.753 0.311 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.9 -54.24 0.21 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -135.12 97.48 3.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.41 -77.91 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.85 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m 58.24 43.19 20.68 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 110.955 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HD1' HD23 ' A' ' 10' ' ' LEU . 46.3 p90 -82.46 -27.9 31.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 m -51.11 -34.37 30.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.779 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.4 p -55.98 -41.47 74.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.189 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.58 -34.77 27.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.402 HD23 ' HD1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -61.18 -42.64 98.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.368 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -61.85 -41.03 97.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.99 -40.15 63.17 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -44.71 89.55 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.225 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -59.51 -43.66 93.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.7 mm-40 -66.8 -42.46 85.93 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.778 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.05 -44.63 87.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -39.73 92.71 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.005 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.28 86.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 15' ' ' GLU . 46.6 t -62.89 -44.88 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.666 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD23 ' HB2' ' A' ' 38' ' ' PRO . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.616 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.25 -132.02 27.74 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.93 -28.78 75.43 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.913 2.408 . . . . 0.0 112.684 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 32.1 2.29 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 t -106.1 -34.02 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.033 179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.99 -45.65 1.1 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.712 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.92 153.81 39.86 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.17 165.9 29.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.685 2.257 . . . . 0.0 112.525 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.3 Cg_endo -67.05 149.71 82.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.725 2.284 . . . . 0.0 112.755 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 85.0 Cg_endo -82.55 -175.51 2.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.107 2.538 . . . . 0.0 112.724 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.936 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.64 0.257 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 74.46 0.24 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -111.45 135.92 51.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.52 63.55 2.58 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.592 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.3 p -139.38 68.37 1.37 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 34.3 m-85 -141.79 -62.07 0.46 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.049 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 83.8 m 74.63 -56.99 0.62 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.247 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -87.3 -41.71 13.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -76.6 -34.78 58.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.164 179.807 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 2.6 tt -65.98 -45.51 81.41 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.921 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 p -62.57 -38.75 91.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.975 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -43.19 75.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -65.22 -43.55 91.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.7 mmt -60.87 -39.06 87.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.803 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -61.73 -45.63 93.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.608 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -35.8 78.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -44.37 95.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.207 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.09 99.67 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 15' ' ' GLU . 31.2 t -62.11 -42.45 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.576 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.33 -131.48 27.23 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.65 -28.64 76.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 m -88.53 48.68 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 111.254 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -138.69 11.36 2.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.989 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.27 92.64 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.735 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.88 137.61 10.24 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.67 0.271 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.61 157.54 61.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.599 2.199 . . . . 0.0 112.825 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 63.4 Cg_endo -73.24 146.13 40.03 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.853 2.369 . . . . 0.0 112.689 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 96.5 Cg_endo -85.49 54.73 3.78 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.089 2.526 . . . . 0.0 112.318 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.805 0.336 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.52 -65.59 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.786 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -109.78 150.46 28.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.96 93.06 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m 69.9 103.02 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.742 0.306 . . . . 0.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.19 -70.29 0.76 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 96.7 m 71.28 -56.82 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.176 0.59 . . . . 0.0 111.265 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -38.84 66.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.506 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -60.21 -38.54 83.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.939 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.11 -41.55 98.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.524 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.58 -41.77 91.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.162 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -44.74 76.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -64.34 -47.64 78.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -41.03 82.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -61.67 -45.27 94.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.768 179.462 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.89 -40.05 87.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -62.68 -40.58 97.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.933 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.59 89.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.004 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 15' ' ' GLU . 59.1 t -62.51 -43.39 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.699 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.5 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.05 -129.26 34.92 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.31 -28.2 78.56 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -96.84 37.74 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.691 0.281 . . . . 0.0 111.692 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 t -113.96 -32.2 6.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.297 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.52 -45.32 1.15 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.719 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.35 153.65 44.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.702 0.287 . . . . 0.0 111.356 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 162.95 40.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.832 2.355 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 50.4 Cg_endo -69.12 136.98 36.17 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 112.635 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.9 Cg_endo -72.88 108.54 2.6 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.763 2.309 . . . . 0.0 112.207 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.859 -179.937 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.593 0.235 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.96 -93.79 0.19 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.468 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -136.06 154.02 51.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.81 0.338 . . . . 0.0 111.481 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.97 -76.34 0.95 Allowed Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.581 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 57.49 41.15 26.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -101.48 -29.74 11.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.423 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -57.21 -34.85 68.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.547 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -44.26 90.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.104 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -76.34 -38.31 56.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.267 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.78 88.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.226 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -70.47 -32.32 69.8 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.746 0.307 . . . . 0.0 110.709 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -74.87 -44.97 46.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.683 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -59.88 -41.68 92.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.492 0.187 . . . . 0.0 111.314 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 20.1 mmt -68.45 -34.77 76.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.586 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -70.27 -44.29 68.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 179.664 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.42 -44.63 95.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.83 -41.12 97.4 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.997 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.74 97.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 15' ' ' GLU . 59.0 t -64.64 -43.01 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.479 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.67 -129.11 49.16 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 -33.48 92.81 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.964 2.443 . . . . 0.0 112.824 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t -91.0 53.32 2.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.973 0.416 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 t -122.62 -37.24 2.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.21 -41.27 1.44 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.486 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.78 154.91 37.66 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.66 0.267 . . . . 0.0 111.263 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 164.9 32.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.698 2.265 . . . . 0.0 112.659 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 51.9 Cg_endo -69.57 133.65 26.44 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.758 2.305 . . . . 0.0 112.631 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 54.6 Cg_endo -70.61 -40.47 3.97 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.756 2.304 . . . . 0.0 112.466 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.04 179.764 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.103 0.477 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.02 111.73 1.72 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.09 165.67 13.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 111.269 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 62.9 0.2 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.576 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m 57.32 62.35 2.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.056 0.455 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -91.73 -29.62 16.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.415 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -57.21 -37.11 71.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.563 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -60.08 -46.63 88.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.89 -34.65 64.5 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.149 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 3.2 tt -63.78 -41.09 98.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.991 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.8 m -68.08 -25.39 65.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.124 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -81.06 -47.29 13.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.437 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 10' ' ' LEU . 3.4 pp0? -62.88 -40.09 96.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.455 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -32.43 70.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.905 179.483 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -69.96 -40.61 75.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.904 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.21 -39.96 76.5 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.27 -39.79 91.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.225 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.48 88.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 23' ' ' ILE . 43.9 t -62.66 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.8 -126.76 39.82 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.39 -28.59 87.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.678 2.252 . . . . 0.0 112.703 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -98.34 30.75 3.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -91.88 -39.33 11.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.5 0.19 . . . . 0.0 110.882 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.82 -44.89 0.84 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.592 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -110.8 164.95 13.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.993 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -68.06 164.76 30.74 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 36.8 Cg_endo -65.99 126.67 16.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.69 2.26 . . . . 0.0 112.539 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 65.8 Cg_endo -75.55 106.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.815 2.343 . . . . 0.0 112.204 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.636 -179.772 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.494 0.188 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.8 54.31 0.57 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.709 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 1.9 tp10 -167.8 146.62 4.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 111.315 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.05 110.44 2.7 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.18 179.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 m 67.66 99.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.725 0.41 . . . . 0.0 112.046 179.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.26 12.93 6.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.436 ' HB ' ' HA ' ' A' ' 3' ' ' GLU . 1.6 m -105.43 -44.25 4.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.628 0.251 . . . . 0.0 110.884 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -68.94 -43.61 74.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.41 -46.63 75.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.879 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -61.89 -40.37 95.19 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.896 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -42.29 86.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.988 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -66.34 -45.16 81.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 44.4 mtm -61.73 -45.77 92.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.932 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.79 -35.44 80.08 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.553 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -42.82 83.99 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.142 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.2 -41.91 94.01 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.32 96.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' GLU . 48.1 t -63.55 -43.93 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.314 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.606 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.76 -133.7 16.02 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.73 -29.31 89.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.856 2.371 . . . . 0.0 112.566 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -102.02 23.71 11.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 t -87.37 -38.82 15.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.538 0.209 . . . . 0.0 110.982 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.58 -45.67 0.71 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.596 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -110.22 162.85 18.8 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.687 0.28 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 47.9 Cg_endo -69.34 165.64 29.78 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.759 2.306 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.7 Cg_endo -66.04 138.39 52.11 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.74 2.294 . . . . 0.0 112.582 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -71.75 116.55 4.75 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.803 2.336 . . . . 0.0 112.548 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.781 179.871 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.703 0.287 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.07 52.72 50.34 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -104.06 154.95 19.1 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.45 -56.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.559 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m 62.8 79.93 0.24 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.4 m-85 -94.88 11.38 31.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -103.49 -36.69 7.88 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.559 0.218 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -87.72 -47.34 8.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.233 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.18 -48.88 66.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.524 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -61.2 -39.69 91.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.066 179.755 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 t -64.98 -40.16 94.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.033 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -66.9 -40.11 87.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.014 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.73 -43.93 78.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.458 ' HG3' HD23 ' A' ' 10' ' ' LEU . 28.8 mtt -67.47 -24.77 65.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.569 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -84.31 -37.02 22.16 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.19 -44.64 94.81 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.476 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -35.02 72.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.265 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.34 86.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t -59.82 -48.23 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.66 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.483 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.12 -133.24 14.62 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.09 -29.87 90.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.77 2.314 . . . . 0.0 112.643 179.786 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -99.86 17.24 21.32 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -80.0 -39.58 29.72 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.506 0.193 . . . . 0.0 110.87 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.79 -48.26 0.62 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.469 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -107.18 161.55 22.61 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 41.0 Cg_endo -67.48 165.62 26.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.734 2.29 . . . . 0.0 112.457 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.6 Cg_endo -65.85 143.15 72.31 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.732 2.288 . . . . 0.0 112.836 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.4 Cg_endo -80.87 67.71 8.56 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.988 2.459 . . . . 0.0 112.47 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.021 -179.96 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.492 0.186 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.3 -82.81 1.61 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.403 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -111.32 98.41 7.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.06 1.06 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 t -156.79 38.55 0.32 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.926 0.393 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.72 -44.8 4.98 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -72.96 -44.88 60.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -63.55 -42.73 98.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.82 -41.31 83.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -42.19 98.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -61.1 -40.34 93.38 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -45.61 66.76 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -65.94 -46.91 76.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.125 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 34.6 mmt -62.28 -29.98 70.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -70.33 -43.98 69.17 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.969 179.635 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 -53.74 53.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.239 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -32.39 72.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.15 77.81 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.238 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 15' ' ' GLU . 97.8 t -61.62 -45.52 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 19' ' ' VAL . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.506 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.41 -128.26 43.45 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.47 -27.26 84.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.706 2.271 . . . . 0.0 112.462 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 t -96.64 22.81 7.6 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.812 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -86.45 -40.2 15.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.606 0.241 . . . . 0.0 110.644 179.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.76 -48.0 0.89 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -97.43 160.25 29.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.608 0.242 . . . . 0.0 111.021 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.08 160.98 44.78 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.65 2.233 . . . . 0.0 112.528 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.506 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.2 Cg_endo -68.42 129.56 19.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.851 2.367 . . . . 0.0 112.675 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.2 Cg_endo -85.43 54.75 3.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.022 2.482 . . . . 0.0 112.331 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.059 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 m80 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -74.42 1.28 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.555 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.0 152.09 23.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.11 -107.16 0.66 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.509 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -128.08 74.35 1.54 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.52 -29.57 18.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.461 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -56.73 -34.18 67.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.534 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -58.02 -43.69 86.88 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.76 179.561 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -31.18 64.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.354 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -46.7 88.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 -41.62 93.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -69.54 -44.1 71.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.106 179.739 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -63.61 -41.31 98.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.484 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -49.12 76.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.991 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.45 -39.74 74.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.691 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 2.1 tt0 -58.96 -36.0 74.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.523 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.04 -45.51 86.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.341 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.57 65.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 23' ' ' ILE . 61.8 t -61.5 -42.32 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.491 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.38 -132.24 41.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.23 -30.76 74.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.893 2.395 . . . . 0.0 112.762 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 p -93.33 41.49 1.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.621 -179.733 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -115.29 -33.7 5.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.247 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.11 -44.82 1.0 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -107.61 157.28 36.2 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.61 0.243 . . . . 0.0 111.504 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 56.5 Cg_endo -70.57 169.53 19.73 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.768 2.312 . . . . 0.0 112.441 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 144.39 81.04 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.643 2.229 . . . . 0.0 112.838 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 52.2 Cg_endo -69.75 154.96 67.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.0 2.466 . . . . 0.0 112.655 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.944 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 -41.41 1.63 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.6 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.15 79.54 0.25 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 -77.12 1.31 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.375 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -107.47 49.18 0.81 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.544 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -93.54 7.8 43.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.743 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -109.45 -35.62 6.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.579 0.228 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 t -91.75 -45.24 8.53 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.31 -44.79 64.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.235 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.15 -45.48 93.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.752 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.2 p -61.47 -36.83 81.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.59 -43.92 79.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.982 179.855 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -70.1 -45.08 67.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.027 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -45.72 90.72 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -67.08 -38.42 85.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.12 179.685 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.73 -40.21 75.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.177 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.56 -40.88 88.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.611 179.466 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 23' ' ' ILE . 32.4 t -60.41 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.756 179.687 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.92 -127.68 44.74 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.41 -29.32 89.84 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.754 2.303 . . . . 0.0 112.56 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -98.92 38.49 1.37 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.601 -179.936 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -101.81 -38.82 7.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.816 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.32 -50.14 0.67 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -100.82 163.49 17.96 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.067 179.699 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 57.0 Cg_endo -71.03 163.25 39.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.575 2.184 . . . . 0.0 112.398 179.782 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 38.2 Cg_endo -66.54 125.31 13.67 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.594 2.196 . . . . 0.0 112.565 -179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.8 Cg_endo -73.08 106.05 2.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.827 2.351 . . . . 0.0 112.114 179.859 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.703 -179.514 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.4 t60 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.31 -123.02 2.48 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.54 56.1 1.86 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.074 0.464 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 55.93 0.02 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.755 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -132.64 25.86 4.38 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.719 0.295 . . . . 0.0 111.238 179.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.81 -25.83 22.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.591 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 t -57.58 -37.07 72.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.563 0.22 . . . . 0.0 111.168 179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -89.5 -39.44 13.33 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.073 179.567 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.08 -41.26 99.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 7.9 tp -63.02 -38.5 91.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.001 179.754 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -61.68 -36.55 81.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.045 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -71.87 -48.85 42.95 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.302 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 10' ' ' LEU . 13.3 pt20 -66.29 -33.27 75.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.1 mmm -70.14 -35.8 74.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.569 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 -47.83 34.58 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.573 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 12.6 pt-20 -58.95 -35.69 73.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -39.73 80.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.794 179.402 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.37 79.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.044 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 23' ' ' ILE . 78.1 t -61.39 -45.03 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.73 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.28 32.62 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.13 -25.41 72.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.815 2.343 . . . . 0.0 112.781 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -93.85 34.97 1.17 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 111.649 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -112.61 -32.03 6.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.116 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.67 -44.13 1.31 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.699 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.74 151.76 50.53 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.303 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 160.61 48.92 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.75 2.3 . . . . 0.0 112.541 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -70.27 130.31 18.5 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.788 2.325 . . . . 0.0 112.654 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.0 Cg_endo -73.11 109.29 2.8 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.766 2.311 . . . . 0.0 112.401 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.136 -179.961 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.49 0.186 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.79 -58.1 1.13 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 68.56 155.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.959 0.409 . . . . 0.0 111.495 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.3 65.31 2.28 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.2 p -123.97 -120.53 0.27 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.688 0.28 . . . . 0.0 110.481 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -79.69 -29.41 40.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.378 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -59.88 -38.78 83.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.59 -179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 p -64.1 -42.65 96.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.174 179.844 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -37.05 69.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -35.79 80.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.005 179.75 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 m -60.16 -42.84 95.78 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -34.07 62.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.599 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -67.62 -31.97 72.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.28 179.734 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.8 mtp -77.27 -31.46 54.93 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.9 tp10 -79.25 -40.13 31.36 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.392 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.55 -35.48 76.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 -179.746 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -71.38 -38.45 71.53 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.696 0.284 . . . . 0.0 110.813 179.512 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.92 89.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.4 t -64.97 -44.7 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.487 179.292 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 19' ' ' VAL . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.539 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -131.21 45.32 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.17 -35.22 42.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -70.67 -21.09 62.63 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.93 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -64.02 -26.49 68.59 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.63 37.6 4.44 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.72 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.86 147.22 15.95 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 110.739 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.62 155.35 70.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.382 2.054 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.97 136.19 26.88 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.886 2.391 . . . . 0.0 112.609 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -66.92 -44.53 5.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.907 2.405 . . . . 0.0 112.389 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 6.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.059 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.39 101.85 0.24 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.26 121.55 19.2 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.665 0.269 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.85 7.1 45.19 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.438 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 t 38.73 66.56 0.51 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.17 0.509 . . . . 0.0 111.88 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.35 -32.94 69.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.598 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -59.65 -49.52 77.44 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -38.86 81.2 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -40.1 95.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.275 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -40.12 94.91 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -62.84 -45.09 94.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.046 179.653 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -40.18 94.08 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -66.15 -46.16 78.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mtt -62.43 -45.09 94.66 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.933 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.7 mt-10 -66.65 -35.0 79.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.95 -38.91 73.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.415 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -45.25 93.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.221 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.85 -38.94 92.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 15' ' ' GLU . 48.6 t -61.9 -39.81 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.487 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.504 ' CD1' HG12 ' A' ' 19' ' ' VAL . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.507 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.614 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.06 -131.54 30.6 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.27 -27.79 72.25 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 112.869 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.51 26.83 3.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -103.35 -32.1 9.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.381 0.134 . . . . 0.0 111.106 179.44 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.5 -46.28 1.09 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.34 154.19 46.57 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.814 0.34 . . . . 0.0 111.381 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.2 164.18 36.43 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.834 2.356 . . . . 0.0 112.534 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.04 136.53 38.25 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.64 2.227 . . . . 0.0 112.629 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.91 139.16 35.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.901 2.401 . . . . 0.0 112.577 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.436 -0.793 . . . . 0.0 110.905 179.873 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.47 171.29 33.31 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.717 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -178.25 6.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.618 0.246 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.03 30.84 4.03 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.831 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -152.08 91.07 1.58 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.477 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.534 ' O ' ' HB ' ' A' ' 7' ' ' THR . 89.3 m-85 -117.13 -49.91 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.676 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.4 m 75.96 -55.88 0.6 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.743 0.652 . . . . 0.0 111.276 -179.437 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 p -84.75 -43.79 13.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.18 -37.37 57.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -63.86 -43.86 94.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 179.857 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -60.53 -39.72 88.9 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.013 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -67.53 -42.68 82.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.727 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -63.08 -40.7 98.44 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.0 mtp -58.3 -45.83 87.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.9 mt-10 -73.63 -36.09 65.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.0 -42.02 84.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -59.68 -39.9 86.07 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.748 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.32 -37.48 87.23 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.591 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 15' ' ' GLU . 32.3 t -63.78 -47.54 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.18 -133.58 12.27 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.42 -31.63 95.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.69 2.26 . . . . 0.0 112.656 179.818 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.23 33.7 3.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.711 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 t -97.53 -38.64 9.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.545 0.212 . . . . 0.0 110.952 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.39 -53.33 0.54 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.505 -179.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -98.75 158.26 32.77 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.578 0.228 . . . . 0.0 111.122 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 46.0 Cg_endo -69.1 165.36 30.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.719 2.279 . . . . 0.0 112.661 -179.901 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.01 132.97 33.87 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.624 2.216 . . . . 0.0 112.393 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 52.3 Cg_endo -69.59 151.09 69.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.861 2.374 . . . . 0.0 112.621 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.392 179.943 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 23' ' ' ILE . 40.3 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.512 0.196 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 19' ' ' VAL . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.1 t . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.496 0.189 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.619 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 23' ' ' ILE . 16.2 t . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.495 0.188 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' HG12 ' A' ' 19' ' ' VAL . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.571 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.641 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 23' ' ' ILE . 63.9 t . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.538 0.209 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.501 ' CD1' HG12 ' A' ' 19' ' ' VAL . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.7 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG12 HD11 ' A' ' 23' ' ' ILE . 39.2 t . . . . . 0 N--CA 1.462 0.175 0 CA-C-O 120.571 0.224 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 19' ' ' VAL . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.636 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 120.59 0.233 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.499 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 23' ' ' ILE . 19.9 t . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 120.618 0.246 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.54 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' CD1' ' A' ' 23' ' ' ILE . 94.6 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.488 0.185 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.718 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 19' ' ' VAL . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 23' ' ' ILE . 31.8 t . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 120.7 0.286 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 19' ' ' VAL . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 120.631 0.253 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 23' ' ' ILE . 25.1 t . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 19' ' ' VAL . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 HG12 ' CD1' ' A' ' 23' ' ' ILE . 57.5 t . . . . . 0 N--CA 1.463 0.2 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.612 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 19' ' ' VAL . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.492 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 120.454 0.168 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 23' ' ' ILE . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 20' ' ' ARG . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.53 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.508 HG12 ' CD1' ' A' ' 23' ' ' ILE . 22.5 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.671 0.272 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 23' ' ' ILE . 46.8 t . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.462 0.172 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 19' ' ' VAL . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.635 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t . . . . . 0 N--CA 1.462 0.136 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.4 t . . . . . 0 N--CA 1.464 0.27 0 CA-C-O 120.465 0.174 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.658 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 19' ' ' VAL . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 23' ' ' ILE . 67.7 t . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.543 0.211 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 23' ' ' ILE . 35.6 t . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 23' ' ' ILE . 21.8 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 120.576 0.227 . . . . 0.0 110.742 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 19' ' ' VAL . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.476 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.613 0.244 . . . . 0.0 110.577 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG12 ' CD1' ' A' ' 23' ' ' ILE . 46.6 t . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 120.589 0.233 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.51 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.616 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 23' ' ' ILE . 31.2 t . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG12 ' CD1' ' A' ' 23' ' ' ILE . 59.1 t . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.501 0.191 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.5 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG12 ' CD1' ' A' ' 23' ' ' ILE . 59.0 t . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 120.528 0.204 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 23' ' ' ILE . 43.9 t . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.571 0.224 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 HD11 ' A' ' 23' ' ' ILE . 48.1 t . . . . . 0 N--CA 1.461 0.122 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.606 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t . . . . . 0 N--CA 1.462 0.129 0 CA-C-O 120.48 0.181 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.8 t . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.504 0.192 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 19' ' ' VAL . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 23' ' ' ILE . 61.8 t . . . . . 0 N--CA 1.464 0.238 0 CA-C-O 120.553 0.216 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 23' ' ' ILE . 32.4 t . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.378 0.132 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 23' ' ' ILE . 78.1 t . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.586 0.232 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 23' ' ' ILE . 92.4 t . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.503 0.192 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 19' ' ' VAL . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.539 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 23' ' ' ILE . 48.6 t . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.561 0.22 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.504 ' CD1' HG12 ' A' ' 19' ' ' VAL . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.507 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.614 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.3 t . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.507 0.194 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.534 0.207 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.98 -92.95 0.1 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.641 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.6 152.46 20.78 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.78 0.324 . . . . 0.0 111.182 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.04 70.48 0.08 OUTLIER Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.55 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -94.19 61.07 2.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.085 0.469 . . . . 0.0 110.651 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -109.38 -32.64 7.09 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.442 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -58.33 -36.01 72.76 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.549 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -57.73 -47.22 83.04 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.29 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.64 -34.54 53.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.291 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.18 -40.84 95.42 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.236 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -43.69 90.3 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.089 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -69.48 -44.87 70.29 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.707 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -55.32 -38.51 68.81 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.6 mmt -57.99 -44.42 87.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.716 0.294 . . . . 0.0 110.81 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -38.5 88.61 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.24 -37.81 88.81 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.226 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -60.89 -40.87 94.67 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.02 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.5 -37.57 81.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.43 HG12 ' CD1' ' A' ' 23' ' ' ILE . 40.3 t -62.92 -42.71 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -59.05 -44.68 91.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.801 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.98 -44.99 94.53 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.516 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.623 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 50.2 t80 -62.24 -41.36 98.35 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.32 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.43 ' CD1' HG12 ' A' ' 19' ' ' VAL . 38.6 mt -61.51 -45.63 98.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.601 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.73 -38.44 90.52 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.712 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.485 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.5 t90 -63.75 -39.43 94.25 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.973 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.623 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 46.1 mt -70.37 -31.29 68.48 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.833 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.33 -37.95 84.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.405 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -74.67 -12.18 60.37 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.16 -17.21 2.95 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.287 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.24 -132.71 25.75 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.509 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.03 -35.03 89.33 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.986 2.458 . . . . 0.0 112.748 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -95.24 44.5 1.09 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.8 t -116.57 -34.64 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.272 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.28 -42.0 1.48 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.504 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.22 40.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 111.2 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 162.71 41.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.784 2.323 . . . . 0.0 112.579 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.447 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.8 Cg_endo -70.21 139.1 37.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.796 2.331 . . . . 0.0 112.64 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 71.0 Cg_endo -74.85 90.34 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.84 2.36 . . . . 0.0 112.27 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.151 -179.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.517 0.199 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.82 64.49 0.56 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -108.09 136.0 48.5 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.09 -101.85 0.53 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.382 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.9 t -149.34 62.3 1.03 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.111 0.482 . . . . 0.0 110.741 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 65.27 12.74 8.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.121 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -81.62 -51.33 8.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.71 0.291 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -68.45 -35.93 78.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.386 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -71.22 -40.25 71.23 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.305 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.2 mt -61.2 -35.8 78.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.46 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -62.71 -42.95 99.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.82 -34.66 39.33 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.254 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -69.08 -47.65 64.69 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.363 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.1 -40.31 89.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.041 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 19' ' ' VAL . 6.9 mm-40 -69.97 -43.28 71.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.258 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -67.5 -46.92 71.5 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.303 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -61.53 -37.01 82.19 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.087 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.64 -38.76 92.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.146 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 15' ' ' GLU . 82.1 t -64.57 -44.92 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.576 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -62.24 -42.42 99.3 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.736 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 HD23 ' HB2' ' A' ' 38' ' ' PRO . 14.2 tp -65.05 -42.22 94.47 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.292 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.0 t80 -64.22 -41.8 96.87 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.124 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.5 mt -60.99 -45.4 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.453 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.47 -40.28 96.15 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.643 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t90 -63.1 -38.11 89.87 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.579 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.619 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 36.3 mt -72.39 -33.47 67.21 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.618 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -36.65 84.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.265 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 14.9 p30 -76.75 -5.87 49.9 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.94 -16.58 5.53 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.942 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.82 -130.69 17.59 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.63 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.01 -26.88 73.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.986 2.458 . . . . 0.0 112.818 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.75 46.3 1.32 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.907 0.384 . . . . 0.0 111.289 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -136.37 11.13 3.25 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 112.0 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.36 35.59 92.27 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.675 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -155.05 137.34 9.96 Favored Pre-proline 0 C--O 1.233 0.226 0 CA-C-O 120.651 0.262 . . . . 0.0 111.257 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.66 157.71 60.75 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.695 2.263 . . . . 0.0 112.702 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 61.3 Cg_endo -72.32 141.62 35.79 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.735 2.29 . . . . 0.0 112.396 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HB2' HD23 ' A' ' 21' ' ' LEU . 37.5 Cg_endo -65.52 -36.18 35.21 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.694 2.263 . . . . 0.0 112.403 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.928 179.763 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.67 0.271 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -132.17 119.6 2.55 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.83 144.37 30.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.705 0.288 . . . . 0.0 111.123 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.8 -53.27 0.59 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.521 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 t -115.56 67.7 0.71 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.181 0.515 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -98.87 -29.05 13.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.37 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.7 p -63.4 -25.63 68.37 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.764 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -57.69 -52.4 65.59 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.734 0.302 . . . . 0.0 111.152 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.05 -35.04 43.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.962 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.98 -39.12 91.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.215 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -61.03 -40.43 93.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.247 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.79 -43.91 97.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.307 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -73.67 -42.3 61.51 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.177 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.1 90.5 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.025 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.35 -44.99 95.19 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.959 179.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.34 -41.83 90.08 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.274 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -62.21 -40.33 95.73 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.067 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.79 87.81 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.346 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 15' ' ' GLU . 16.2 t -61.05 -38.43 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -59.11 -45.53 90.65 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.063 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.22 -45.59 92.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.454 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.8 t80 -62.53 -41.16 98.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.379 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' CD1' HG12 ' A' ' 19' ' ' VAL . 52.2 mt -62.33 -44.63 99.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.552 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.83 -41.36 86.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.759 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 49.7 t90 -64.78 -36.51 84.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.571 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 45.0 mt -72.3 -32.36 66.52 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.838 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -64.68 -40.0 94.64 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.202 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.9 p30 -71.28 -18.03 62.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.66 -25.17 1.19 Allowed Glycine 0 C--N 1.338 0.646 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.016 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.57 -135.59 19.65 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.473 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.6 -33.05 93.98 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.909 2.406 . . . . 0.0 112.897 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.26 41.39 1.15 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.732 0.301 . . . . 0.0 111.685 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -113.12 -34.73 5.6 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.52 -47.54 0.97 Allowed Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.713 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.21 152.82 40.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.71 0.291 . . . . 0.0 111.254 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.99 165.19 32.05 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.765 2.31 . . . . 0.0 112.569 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.9 Cg_endo -68.32 153.03 75.18 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.758 2.305 . . . . 0.0 112.722 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 86.7 Cg_endo -89.14 43.68 0.69 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.247 2.632 . . . . 0.0 112.644 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.148 -0.93 . . . . 0.0 111.063 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.1 p80 . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.19 178.45 43.58 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.712 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 70.2 156.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.968 0.414 . . . . 0.0 111.42 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.8 62.76 0.93 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.475 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -94.93 39.63 1.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.828 0.346 . . . . 0.0 111.345 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 -33.82 26.07 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.245 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -61.27 -35.2 76.66 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.454 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.3 m -77.1 -36.23 55.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.668 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.15 -50.52 12.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.644 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.68 -40.6 88.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -62.65 -33.28 74.73 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.927 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -40.99 96.39 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.968 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -67.01 -47.79 70.38 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.79 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 7.0 mtt -63.72 -40.11 95.95 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.663 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.0 mm-40 -64.88 -38.77 92.1 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.808 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.77 -40.85 76.61 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.065 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -63.24 -39.52 94.84 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.854 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.67 94.65 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.123 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 15' ' ' GLU . 44.9 t -64.81 -45.47 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.252 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.28 -41.99 98.96 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.613 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.6 mt -64.73 -44.24 90.8 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.3 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.641 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.2 t80 -62.77 -42.17 99.57 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.07 178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.98 -48.12 90.5 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.259 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.54 -38.22 89.14 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.476 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 67.3 t90 -61.92 -43.51 98.7 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.673 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.9 mt -68.29 -43.35 77.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.829 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -34.34 74.61 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -71.51 -22.6 61.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.418 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.2 -15.72 1.5 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.144 -0.55 . . . . 0.0 113.336 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.11 -133.74 13.36 Favored Glycine 0 C--N 1.339 0.719 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.241 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.17 -31.18 94.89 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.74 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 t -101.8 32.91 3.2 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.4 t -97.32 -38.48 9.64 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.502 0.191 . . . . 0.0 110.911 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.47 -60.45 0.42 Allowed Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.523 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -93.84 163.37 24.21 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 56.6 Cg_endo -70.52 164.4 35.44 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.6 Cg_endo -68.12 125.86 13.61 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.586 2.191 . . . . 0.0 112.756 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.2 Cg_endo -78.03 121.87 5.55 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.885 2.39 . . . . 0.0 112.392 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.143 -179.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 33.6 m80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.517 0.198 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.35 -59.57 0.56 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.78 87.49 0.11 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.71 -103.18 2.83 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.42 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -120.44 45.06 2.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.71 -16.01 43.23 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.872 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.0 t -54.77 -39.65 68.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.672 0.272 . . . . 0.0 111.355 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 m -90.26 -34.78 15.63 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.105 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -61.89 -42.79 99.49 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.253 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -46.21 90.09 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -61.96 -41.32 97.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.124 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 ttmt -70.46 -39.13 74.47 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.224 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -58.43 -42.57 87.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.057 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.7 mtm -56.11 -42.11 76.33 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.93 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -33.47 71.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.341 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -56.32 -36.28 68.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.541 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -59.93 -46.19 90.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 111.17 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -43.89 90.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.044 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.501 HG12 ' CD1' ' A' ' 23' ' ' ILE . 63.9 t -62.08 -38.65 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -43.11 99.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.814 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -62.78 -45.71 91.39 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.372 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.7 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 38.7 t80 -62.21 -44.11 97.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.308 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.501 ' CD1' HG12 ' A' ' 19' ' ' VAL . 57.3 mt -61.32 -44.34 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.487 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -63.24 -40.84 98.55 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.495 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.488 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 71.1 t90 -63.44 -36.02 82.36 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.7 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.3 mt -72.58 -34.06 67.19 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.803 179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.6 mttt -65.37 -34.5 78.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.421 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.2 p30 -78.84 -0.64 31.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.63 -2.4 10.2 Favored Glycine 0 C--N 1.339 0.737 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.461 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.74 -129.59 48.65 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.181 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.73 -34.18 63.1 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.767 2.312 . . . . 0.0 112.564 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -27.51 69.13 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.83 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -56.18 -35.81 67.65 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.87 -47.35 1.02 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.52 151.72 59.33 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.588 0.232 . . . . 0.0 111.383 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -68.55 163.32 37.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.722 2.282 . . . . 0.0 112.243 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.426 ' HB3' ' CZ3' ' A' ' 25' ' ' TRP . 38.5 Cg_endo -66.31 146.6 81.35 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.556 2.171 . . . . 0.0 112.817 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HB3' HD23 ' A' ' 21' ' ' LEU . 48.4 Cg_endo -68.71 159.14 54.91 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.021 2.48 . . . . 0.0 112.712 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.226 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m80 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.47 0.176 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.93 44.08 1.58 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.697 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -149.66 87.73 1.51 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.837 0.351 . . . . 0.0 110.834 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.45 58.04 0.41 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.525 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -142.13 85.21 1.91 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.048 0.451 . . . . 0.0 110.502 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.511 ' O ' ' HB ' ' A' ' 7' ' ' THR . 21.6 m-85 -106.14 -62.99 1.31 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.024 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.3 m 73.53 -57.94 0.61 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.405 0.682 . . . . 0.0 111.098 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.6 m -94.22 -40.16 10.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.812 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -70.09 -32.99 71.31 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.022 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.447 HD12 ' HD2' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -63.67 -41.15 98.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.3 m -62.53 -42.87 99.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.995 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.84 -43.16 76.07 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.972 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -39.3 93.34 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.1 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 19.0 mtt -59.69 -41.17 90.14 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.85 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 19' ' ' VAL . 5.2 mm-40 -61.99 -38.47 88.74 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.712 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -61.2 -37.38 82.77 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.005 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -57.01 -44.5 82.88 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.854 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.91 90.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 15' ' ' GLU . 39.2 t -61.62 -39.77 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.607 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -44.38 82.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -45.01 93.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.32 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.173 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 19' ' ' VAL . 36.8 mt -61.25 -46.2 97.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.539 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.27 -39.91 95.93 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.41 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 62.4 t90 -60.19 -41.39 92.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.199 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.636 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 67.8 mt -69.6 -38.86 77.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -60.8 -35.11 75.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.783 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.62 -19.5 62.82 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.138 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.73 -11.33 3.43 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.462 -0.399 . . . . 0.0 112.797 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 -130.32 9.72 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.221 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.86 -24.65 79.66 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.842 2.361 . . . . 0.0 112.805 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 m -98.49 34.51 2.0 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -99.29 -35.06 10.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.864 -0.153 . . . . 0.0 111.059 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.92 -42.95 1.24 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.424 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -109.37 158.0 35.73 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.21 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 36.7 Cg_endo -65.68 163.8 29.03 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.73 2.287 . . . . 0.0 112.509 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.496 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.7 Cg_endo -66.27 134.62 36.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.71 2.273 . . . . 0.0 112.494 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 73.9 Cg_endo -75.23 155.63 41.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.921 2.414 . . . . 0.0 112.521 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.219 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.13 94.29 0.7 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.496 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 63.04 95.52 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.87 57.39 4.07 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.531 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.6 t -141.64 49.02 1.61 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.226 0.536 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.95 11.76 17.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.946 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -104.26 -39.68 6.4 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.527 0.203 . . . . 0.0 111.075 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.6 p -68.37 -50.0 56.18 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.528 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -67.85 -42.56 81.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.466 HD23 ' HG3' ' A' ' 14' ' ' MET . 0.2 OUTLIER -63.88 -32.56 74.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.64 -37.92 85.79 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.069 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -62.58 -51.21 68.22 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.118 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -69.73 -38.56 76.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.448 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.466 ' HG3' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -63.03 -38.06 89.7 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.048 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' O ' HG23 ' A' ' 19' ' ' VAL . 5.1 mm-40 -60.85 -43.79 97.85 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.821 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -72.49 -44.4 62.33 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.792 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.06 -39.69 90.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.108 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.93 94.47 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 15' ' ' GLU . 64.0 t -64.32 -43.54 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.381 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.36 -44.56 96.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.548 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.57 -43.07 98.08 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.281 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.542 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 62.3 t80 -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.175 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mt -60.78 -46.02 96.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.369 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 30.5 tt0 -65.49 -31.72 72.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.931 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.499 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 69.1 t90 -70.94 -31.75 68.44 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.4 mt -77.23 -38.61 50.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.551 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 10.6 ptpt -65.18 -31.08 72.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.4 p30 -77.79 -13.46 59.88 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.92 -18.94 2.54 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.289 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.7 -131.79 26.45 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.393 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.67 -30.93 79.2 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.908 2.406 . . . . 0.0 112.673 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 p -95.0 33.22 1.54 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -108.57 -32.87 7.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.196 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.74 -47.07 1.03 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.778 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.76 154.12 42.17 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.701 0.286 . . . . 0.0 111.196 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.86 164.0 36.81 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.805 2.336 . . . . 0.0 112.642 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.12 134.97 33.21 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.708 2.272 . . . . 0.0 112.705 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.7 Cg_endo -72.76 94.69 0.79 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.929 2.419 . . . . 0.0 112.224 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.018 -0.992 . . . . 0.0 111.188 -179.802 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.88 -113.88 2.18 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.643 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.74 139.54 37.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.28 80.55 0.2 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.912 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.51 32.73 18.74 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.851 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.3 OUTLIER 61.09 17.44 8.03 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.909 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 m -107.14 -42.98 4.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.13 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -37.68 88.43 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.88 -39.7 23.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.313 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -63.62 -39.42 94.3 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.232 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 65.1 p -60.99 -37.6 83.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.033 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -63.58 -43.84 95.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.837 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -69.65 -41.23 75.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.122 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.2 mmt -58.16 -47.23 84.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.003 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.6 mm-40 -63.85 -38.13 89.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.975 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.97 -40.22 84.1 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.333 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -59.58 -42.27 92.13 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.207 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.06 93.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.101 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 15' ' ' GLU . 19.9 t -63.82 -41.53 92.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.498 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -60.12 -42.8 95.54 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.1 mt -64.41 -45.38 87.84 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.402 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.7 t80 -62.6 -41.72 99.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.291 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.8 mt -61.57 -43.97 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.661 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -63.29 -39.74 95.41 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.582 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.54 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.2 t90 -61.87 -40.25 94.7 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.556 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 68.2 mt -69.8 -30.75 68.36 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.675 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.74 85.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.28 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -74.37 -10.58 59.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.07 -18.1 2.94 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.161 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.77 -132.06 28.99 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.365 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.42 -30.11 79.96 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.951 2.434 . . . . 0.0 112.842 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 t -99.5 39.51 1.3 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -112.25 -32.93 6.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.44 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 135.53 -46.04 1.06 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.633 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.44 154.88 37.38 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.834 0.35 . . . . 0.0 111.374 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.14 166.82 27.99 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.879 2.386 . . . . 0.0 112.551 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.11 146.09 75.42 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.74 2.293 . . . . 0.0 112.9 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 84.1 Cg_endo -76.66 -17.81 15.75 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.097 2.531 . . . . 0.0 113.161 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.615 -0.707 . . . . 0.0 111.2 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.57 -163.0 36.79 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.764 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.96 153.83 49.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.767 0.318 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.47 71.25 0.33 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.362 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m 63.62 78.57 0.29 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.996 0.427 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HD1' HD23 ' A' ' 10' ' ' LEU . 37.2 p90 -77.28 -27.24 53.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.429 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.7 t -53.45 -34.09 56.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.575 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 t -57.82 -46.32 84.87 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.67 0.272 . . . . 0.0 110.753 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -74.24 -32.7 63.09 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.988 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.577 HD23 ' HD1' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -59.96 -43.56 94.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.309 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.6 -45.84 92.48 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -67.57 -40.24 84.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.964 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -64.16 -45.23 89.32 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.78 -40.22 83.36 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.043 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 19' ' ' VAL . 27.6 mt-10 -70.32 -47.0 63.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.055 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.72 -46.06 87.15 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.194 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -61.88 -38.62 88.98 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.815 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.48 94.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 15' ' ' GLU . 94.6 t -63.11 -44.94 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -60.36 -42.62 96.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.703 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.73 -44.82 95.23 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.358 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.718 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.0 t80 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HG12 ' A' ' 19' ' ' VAL . 48.2 mt -61.94 -46.25 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.43 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -62.86 -39.45 94.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.401 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.461 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 59.2 t90 -60.79 -42.45 97.59 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.495 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.718 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 83.7 mt -67.83 -41.31 83.23 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.45 -34.46 75.46 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -72.54 -17.99 61.67 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.383 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.36 -9.38 3.22 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.291 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 -133.33 20.86 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.268 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.81 -32.22 95.12 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.714 2.276 . . . . 0.0 112.593 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -98.27 26.17 5.62 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.1 t -88.97 -39.18 13.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.499 0.19 . . . . 0.0 110.901 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 149.6 -46.85 0.64 Allowed Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.488 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.633 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -109.49 164.09 15.56 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-O 120.655 0.264 . . . . 0.0 111.154 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 55.5 Cg_endo -70.4 164.53 34.85 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.715 2.277 . . . . 0.0 112.5 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.461 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.8 Cg_endo -65.96 134.44 37.19 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.731 2.287 . . . . 0.0 112.44 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.454 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.4 Cg_endo -71.67 101.72 1.21 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.792 2.328 . . . . 0.0 112.177 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.227 -179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.3 p80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.739 0.305 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.9 125.7 3.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.595 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.18 169.51 18.06 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.802 0.334 . . . . 0.0 111.278 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.19 85.14 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.78 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -105.34 35.81 2.71 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.127 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -71.55 -31.73 67.33 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.066 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -94.71 -24.38 17.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.435 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.3 m -80.95 -54.12 5.85 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -43.24 98.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.734 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 0.6 OUTLIER -62.13 -35.29 78.31 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.138 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 t -62.55 -42.84 99.79 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.708 0.29 . . . . 0.0 110.884 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -72.28 -43.79 63.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -39.52 91.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.142 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.1 mmt -60.69 -40.46 92.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.787 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 19' ' ' VAL . 8.1 mm-40 -64.6 -35.41 80.9 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.022 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -39.82 81.91 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.024 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.78 -41.05 94.8 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.822 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.29 95.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 23' ' ' ILE . 31.8 t -63.61 -44.17 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.441 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -41.44 90.5 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.851 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -63.32 -45.65 90.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.215 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.621 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.5 t80 -62.54 -41.46 98.89 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.209 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 19' ' ' VAL . 40.8 mt -61.98 -44.79 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.544 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.78 -40.06 91.16 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.65 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.52 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 52.2 t90 -63.38 -38.38 90.94 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.595 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.621 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 58.3 mt -70.9 -32.36 69.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.75 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -64.54 -40.64 95.97 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.157 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.9 p30 -71.2 -18.74 62.46 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.527 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.5 -24.27 1.07 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.997 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.12 -135.56 22.86 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.088 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -62.48 -30.97 80.57 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.918 2.412 . . . . 0.0 112.718 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -95.88 30.94 2.22 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -106.37 -32.84 7.96 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.213 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.51 -45.12 1.17 Allowed Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.94 45.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-O 120.55 0.214 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.56 162.85 40.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.69 2.26 . . . . 0.0 112.639 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HB3' ' CZ3' ' A' ' 25' ' ' TRP . 53.8 Cg_endo -69.84 144.53 53.88 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.622 2.215 . . . . 0.0 112.68 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 22' ' ' PHE . 27.3 Cg_endo -62.24 -41.5 34.3 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.835 2.357 . . . . 0.0 112.376 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.13 -0.938 . . . . 0.0 110.902 179.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.57 0.224 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.69 -102.36 1.77 Allowed Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.573 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.86 158.91 43.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.646 0.26 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.13 -106.7 0.88 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.588 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 5' ' ' THR . 4.8 t -151.58 89.73 1.51 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.141 0.496 . . . . 0.0 110.699 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -85.97 -9.93 56.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.003 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.2 m -55.25 -45.72 76.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.683 0.278 . . . . 0.0 111.116 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.2 m -88.97 -33.1 17.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.251 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -63.56 -37.08 85.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.799 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -43.97 95.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.345 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -61.05 -40.58 94.16 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.636 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -40.37 62.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.88 -50.53 70.52 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.182 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.5 mmt -60.63 -39.34 87.88 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 3.8 tt0 -64.93 -41.84 95.17 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.032 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -60.13 -46.32 90.04 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.468 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -38.44 87.22 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.681 0.276 . . . . 0.0 110.935 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HA ' HD12 ' A' ' 21' ' ' LEU . . . -62.33 -41.21 98.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.22 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 28.7 t -63.05 -42.47 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.542 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -43.03 93.1 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.986 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 18' ' ' ALA . 8.8 mt -63.7 -45.14 91.34 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.455 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.2 t80 -62.26 -40.58 96.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.332 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.67 -46.78 95.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.429 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -63.94 -38.38 90.88 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.348 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.0 t90 -60.81 -40.84 94.22 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.524 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.3 mt -67.74 -40.19 84.17 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -63.65 -31.26 72.38 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -77.07 -5.62 49.58 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.776 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.94 1.41 8.85 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.067 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.83 -128.07 39.8 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.297 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.5 -30.5 90.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.676 2.25 . . . . 0.0 112.568 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -96.21 33.71 1.71 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 t -96.21 -39.03 9.88 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.908 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.83 -46.28 0.71 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.619 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.623 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -113.41 164.0 16.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.951 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 43.7 Cg_endo -66.87 165.14 26.98 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.654 2.236 . . . . 0.0 112.541 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -65.82 130.71 25.34 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.8 2.333 . . . . 0.0 112.6 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.3 Cg_endo -73.62 142.44 32.57 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.839 2.359 . . . . 0.0 112.324 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.444 179.999 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.894 0.378 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 64.57 0.04 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.578 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -110.08 156.2 20.86 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.793 0.33 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -175.73 -86.16 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.466 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 m 70.87 104.12 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.844 0.354 . . . . 0.0 111.242 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.39 11.12 7.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.504 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -96.25 -55.21 3.02 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.871 0.367 . . . . 0.0 110.71 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.5 t -77.58 -39.18 46.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.861 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.3 -44.15 95.82 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.01 -38.82 92.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.695 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -61.78 -40.04 93.8 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.786 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.98 -41.33 99.52 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.739 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -62.16 -47.2 85.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.71 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mmt -63.5 -39.04 93.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.614 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -64.08 -37.38 87.24 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.047 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -62.99 -39.41 94.68 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.852 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.8 92.59 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.764 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' GLU . 25.1 t -62.42 -43.16 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.458 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -42.85 84.45 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -44.92 88.32 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.317 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.8 t80 -61.6 -41.36 97.33 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.178 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 HD11 HG12 ' A' ' 19' ' ' VAL . 37.9 mt -60.2 -46.33 94.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.367 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -62.94 -39.48 94.73 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.566 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.503 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 67.3 t90 -62.37 -37.52 86.04 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.864 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 41.8 mt -72.65 -33.66 66.74 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.758 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -65.64 -34.54 78.46 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.558 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 16.3 p30 -79.04 -3.98 47.87 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.63 -15.23 5.49 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.227 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.27 -129.66 31.72 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.378 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.58 -29.53 70.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.719 2.279 . . . . 0.0 112.782 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -92.5 33.93 1.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -111.23 -29.11 7.97 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.471 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.45 33.95 2.19 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.682 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.63 148.27 3.28 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 120.52 0.2 . . . . 0.0 111.019 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.41 159.76 52.43 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.514 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.73 140.43 46.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.683 2.255 . . . . 0.0 112.567 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.9 Cg_endo -71.18 117.41 5.14 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.847 2.365 . . . . 0.0 112.396 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.48 -0.771 . . . . 0.0 111.11 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.474 0.178 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.72 -124.14 2.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.658 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -152.37 146.39 25.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.929 0.395 . . . . 0.0 111.323 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.23 10.87 83.11 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.936 -0.574 . . . . 0.0 113.206 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.8 p -113.93 51.44 0.87 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.021 0.438 . . . . 0.0 110.592 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.519 ' O ' ' HB ' ' A' ' 7' ' ' THR . 12.7 m-85 -120.84 -60.97 1.61 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.948 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 71.1 m 74.19 -55.82 0.65 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.246 0.618 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -80.48 -41.99 23.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.316 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 6' ' ' PHE . 26.4 t70 -63.68 -44.17 94.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.179 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.448 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -62.04 -38.56 89.2 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.8 m -61.56 -39.16 90.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.075 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -48.3 60.04 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -60.58 -36.4 78.44 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.6 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.0 mmt -57.58 -39.15 76.13 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.229 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.6 mm-40 -62.48 -47.02 85.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.221 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -62.16 -45.5 93.16 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.29 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -60.7 -38.41 84.92 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.05 91.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.348 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 15' ' ' GLU . 57.5 t -63.08 -41.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.464 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.12 -44.44 94.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.831 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.87 -45.02 91.3 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.411 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.612 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.1 t80 -61.33 -41.49 97.11 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.17 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' CD1' HG12 ' A' ' 19' ' ' VAL . 40.4 mt -60.62 -47.7 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.481 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.92 -37.84 86.16 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.627 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.521 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 65.8 t90 -64.69 -38.76 92.11 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.222 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.612 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 35.5 mt -71.46 -33.58 69.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.594 0.235 . . . . 0.0 111.069 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -67.91 -34.72 77.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.82 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.5 p30 -77.0 -9.46 58.71 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.94 -16.6 3.25 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.852 -0.69 . . . . 0.0 113.241 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.52 -132.79 27.49 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.437 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.14 -31.57 83.03 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.931 2.421 . . . . 0.0 112.711 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 m -96.39 40.94 1.12 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 111.73 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.3 t -114.53 -33.88 5.41 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.236 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 132.65 -46.62 1.05 Allowed Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.801 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.09 154.96 45.09 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 111.3 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.39 162.67 40.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.844 2.363 . . . . 0.0 112.678 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.521 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 57.0 Cg_endo -70.49 128.86 15.93 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.762 2.308 . . . . 0.0 112.674 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 68.7 Cg_endo -75.98 101.32 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.822 2.348 . . . . 0.0 112.517 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.9 p . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.127 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.734 0.302 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.19 140.4 7.46 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.438 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.32 133.89 11.88 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.669 0.271 . . . . 0.0 110.8 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.85 84.19 0.19 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.624 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 t 42.32 46.19 3.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 111.676 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.81 -42.71 8.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.709 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 p -65.26 -44.36 88.34 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 88.0 p -63.36 -39.16 93.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.966 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.58 -41.19 69.31 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.188 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.46 -43.72 98.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.078 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 t -63.58 -40.99 98.38 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.091 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -71.46 -40.47 70.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.981 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.48 -45.97 92.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 88.1 mtp -57.07 -46.07 82.78 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.076 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -66.22 -44.01 85.04 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.94 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -37.85 88.63 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.59 -39.75 92.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.813 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.13 89.55 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.936 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 t -62.71 -42.34 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.57 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' HA ' HD12 ' A' ' 23' ' ' ILE . 17.0 mtm180 -57.67 -42.99 84.71 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.851 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.94 -44.02 94.1 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.266 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.7 t80 -63.05 -39.55 95.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.265 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 20' ' ' ARG . 31.8 mt -61.44 -45.82 97.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.265 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -62.13 -39.93 94.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.53 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.0 t90 -62.42 -40.42 96.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.749 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 30.4 mt -69.28 -31.86 70.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.66 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -66.47 -36.05 81.8 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.347 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.5 p30 -79.55 -1.48 37.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 131.69 -19.44 4.74 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.985 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 -131.02 30.18 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.315 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.12 -27.03 73.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.938 2.425 . . . . 0.0 112.905 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -95.47 21.23 8.41 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -96.89 -33.04 11.76 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.464 0.173 . . . . 0.0 111.108 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.88 -51.39 0.86 Allowed Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.703 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.6 60.01 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.737 0.303 . . . . 0.0 111.404 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -70.0 162.22 43.03 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.697 2.265 . . . . 0.0 112.628 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 55.6 Cg_endo -69.02 138.05 39.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.684 2.256 . . . . 0.0 112.56 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 57.1 Cg_endo -71.33 118.96 5.94 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.846 2.364 . . . . 0.0 112.623 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.162 -0.923 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.688 0.28 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.07 -141.45 3.13 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.687 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 64.19 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.831 0.348 . . . . 0.0 111.427 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.81 -52.66 0.76 Allowed Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.637 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.2 p -130.9 40.61 3.46 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.903 0.382 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.1 -28.45 16.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.387 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.1 p -56.19 -36.18 68.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.663 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.38 -44.47 92.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.37 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -79.83 -37.8 34.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -42.49 98.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.213 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -62.72 -42.64 99.76 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.962 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.4 mttt -68.96 -42.72 76.27 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.9 -40.02 95.53 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.911 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -61.35 -39.95 92.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.692 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.2 mt-10 -62.54 -41.56 98.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.786 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -58.24 -40.41 81.67 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.11 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.1 -41.33 92.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.143 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.9 -41.94 97.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.977 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.508 HG12 ' CD1' ' A' ' 23' ' ' ILE . 22.5 t -62.72 -40.85 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.442 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttt-85 -59.79 -44.22 94.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.794 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -44.77 92.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.418 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.648 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.5 t80 -63.08 -42.82 99.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.4 mt -60.99 -43.97 97.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -63.34 -39.89 95.79 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.599 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 53.6 t90 -63.48 -40.0 95.94 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.648 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 34.9 mt -70.95 -34.82 71.82 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.719 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -63.77 -39.35 94.05 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.421 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 15.6 p30 -73.0 -14.81 61.5 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.95 -19.03 2.35 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.182 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.69 -132.13 24.31 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.288 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.79 -35.73 66.52 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.965 2.443 . . . . 0.0 112.534 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -94.99 42.46 1.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 111.716 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.9 t -116.31 -33.19 5.04 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.409 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.22 36.08 1.69 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.424 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.45 145.82 4.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.561 0.219 . . . . 0.0 111.017 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.51 156.77 64.74 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.596 2.198 . . . . 0.0 112.682 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 59.5 Cg_endo -70.83 142.84 44.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.859 2.372 . . . . 0.0 112.435 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 57.8 Cg_endo -71.46 104.89 1.65 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.772 2.315 . . . . 0.0 112.364 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.9 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.032 -179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.832 0.348 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.49 64.35 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.59 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 62.57 89.25 0.09 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.958 0.409 . . . . 0.0 111.275 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.26 69.5 0.05 OUTLIER Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.678 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -116.46 50.97 1.01 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.123 0.487 . . . . 0.0 110.838 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -162.0 79.28 0.54 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.13 0.967 . . . . 0.0 110.903 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -111.29 -40.9 4.28 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.234 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.5 p -69.02 -44.73 72.15 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.149 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.28 87.73 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.11 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -63.04 -45.94 89.88 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -63.04 -38.75 92.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.955 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -67.31 -40.16 85.99 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.204 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.429 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 46.7 mt-30 -65.75 -33.25 75.43 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.265 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 46.6 mtp -68.24 -33.23 74.01 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.686 0.279 . . . . 0.0 110.832 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.4 mt-10 -72.71 -47.15 49.53 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.821 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.0 -35.61 75.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.789 -0.187 . . . . 0.0 111.366 -179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.71 -36.41 67.82 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.895 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.8 -35.99 79.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.048 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 15' ' ' GLU . 46.8 t -62.11 -43.77 98.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.668 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -58.2 -43.58 87.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.001 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.427 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.7 mm? -63.34 -45.48 91.02 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.4 t80 -62.37 -42.79 99.68 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.34 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 19' ' ' VAL . 49.1 mt -61.59 -44.6 98.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.498 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.01 -40.69 94.5 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.513 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 55.8 t90 -63.73 -38.48 91.28 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.635 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.5 mt -70.96 -32.22 69.02 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.789 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -66.19 -36.13 82.28 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.485 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.1 p30 -77.81 -4.42 46.44 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.12 -14.9 5.11 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.104 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.23 -130.26 35.09 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.348 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.13 -28.96 80.35 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.865 2.377 . . . . 0.0 112.703 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -97.13 40.82 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.673 0.273 . . . . 0.0 111.708 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 t -114.2 -33.86 5.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.21 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.07 -47.58 0.96 Allowed Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.705 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.94 154.07 37.52 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.668 0.271 . . . . 0.0 111.304 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.59 168.36 20.09 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.686 2.258 . . . . 0.0 112.486 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.9 153.59 77.33 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.67 2.247 . . . . 0.0 112.8 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 89.4 Cg_endo -81.98 -1.33 10.78 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.148 2.565 . . . . 0.0 113.491 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.713 -0.661 . . . . 0.0 111.448 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 8.0 t60 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.615 0.245 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.45 -92.44 0.24 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.523 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.36 119.79 22.2 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.25 56.28 0.1 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.455 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 p -138.89 46.9 1.95 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.931 0.396 . . . . 0.0 110.723 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.07 -32.42 63.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.625 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -61.68 -48.44 80.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.141 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 98.2 p -65.47 -40.36 93.06 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -36.12 80.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.367 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.23 -39.19 93.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.924 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 m -60.69 -44.39 96.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.087 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -75.71 -37.04 59.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.252 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.47 -43.6 98.58 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.19 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.0 mtt -59.3 -45.78 90.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.964 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.24 -42.93 87.92 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.872 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.12 -42.1 98.89 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.142 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.0 -38.83 87.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.039 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.03 88.59 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 23' ' ' ILE . 43.2 t -61.04 -52.08 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.452 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -41.5 79.83 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.764 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -42.46 98.82 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.69 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 39.4 t80 -64.06 -36.53 84.3 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.858 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.5 mm -61.1 -47.4 93.74 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.21 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -63.61 -38.05 89.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.431 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.519 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 58.9 t90 -61.52 -38.97 89.33 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.897 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 53.4 mt -71.61 -32.47 68.03 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.816 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HE2' HG22 ' A' ' 23' ' ' ILE . 4.0 mtmt -66.96 -36.92 83.29 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.0 p30 -76.53 -8.22 56.74 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.092 0.405 . . . . 0.0 112.092 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.2 -15.31 3.97 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.314 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 -131.84 31.95 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.502 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.86 -31.88 77.55 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.919 2.413 . . . . 0.0 112.755 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 t -96.29 40.95 1.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.712 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.3 t -113.34 -31.26 6.63 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.22 32.78 2.1 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.605 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.42 148.06 4.05 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-O 120.618 0.247 . . . . 0.0 110.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.64 158.33 58.17 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.598 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -69.17 138.29 39.31 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.764 2.309 . . . . 0.0 112.252 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 49.2 Cg_endo -69.04 109.29 2.14 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.738 2.292 . . . . 0.0 112.498 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.194 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.037 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.707 0.289 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.66 -137.11 12.61 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.677 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -130.4 143.53 50.82 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.983 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.71 49.23 1.11 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.73 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m 59.34 86.74 0.09 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.272 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -66.41 -31.23 71.85 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.389 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -60.65 -34.24 73.99 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.353 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 t -56.71 -48.2 78.24 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.057 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.7 -36.88 62.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.064 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.68 -38.82 82.55 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.119 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -47.4 85.45 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.994 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -70.41 -40.91 73.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.98 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -57.88 -43.07 85.82 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.03 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -42.69 93.45 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.816 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.73 -39.68 88.07 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -43.23 96.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.995 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.83 -39.27 91.2 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.981 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.71 -37.32 83.71 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.113 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 23' ' ' ILE . 97.4 t -62.88 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.684 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -43.21 93.32 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.604 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -64.12 -44.88 90.88 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.383 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.658 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.9 t80 -62.14 -41.15 97.99 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.426 ' CD1' HG12 ' A' ' 19' ' ' VAL . 41.8 mt -61.17 -48.35 89.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.417 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -61.7 -39.48 91.64 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.363 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 58.6 t90 -60.99 -42.4 98.32 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.549 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.7 mt -68.9 -39.2 79.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -33.31 74.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.023 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.97 -7.35 54.4 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.617 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.94 6.89 7.51 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.135 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.92 -126.45 38.84 Favored Glycine 0 C--N 1.341 0.809 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.653 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.05 -31.72 93.82 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.646 2.231 . . . . 0.0 112.423 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.36 50.76 1.26 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.945 0.403 . . . . 0.0 111.228 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 m -112.61 -39.39 4.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.93 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 143.53 -40.11 1.24 Allowed Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.4 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.535 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -115.96 161.65 29.79 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.519 0.2 . . . . 0.0 110.94 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 47.7 Cg_endo -68.33 165.15 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.615 2.21 . . . . 0.0 112.344 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 29.5 Cg_endo -63.2 132.3 35.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.65 2.233 . . . . 0.0 112.488 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' CB ' HD23 ' A' ' 21' ' ' LEU . 56.1 Cg_endo -70.54 134.15 25.71 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.803 2.336 . . . . 0.0 112.593 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.904 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 30.4 m80 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.515 0.197 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.61 62.32 0.43 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.58 137.12 33.18 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 111.128 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.65 -53.99 2.31 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.551 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m 62.09 32.11 17.62 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.714 0.292 . . . . 0.0 111.245 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.74 15.56 5.96 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 m -103.94 -51.91 3.06 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.252 . . . . 0.0 111.117 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 p -65.72 -40.12 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.22 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.12 -41.59 77.17 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.03 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -43.57 98.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.02 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -42.0 98.73 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.736 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -43.09 89.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.855 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -67.31 -38.52 85.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.021 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 4.2 mtt -60.36 -40.15 89.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.884 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -60.65 -41.2 94.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -62.98 -40.32 97.39 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.805 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.72 -39.22 87.79 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.784 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' A' ' 21' ' ' LEU . . . -60.14 -38.32 82.73 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG12 ' CD1' ' A' ' 23' ' ' ILE . 67.7 t -62.46 -45.3 99.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.579 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -43.25 97.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.809 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 18' ' ' ALA . 7.4 mt -64.51 -44.33 91.28 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.243 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.639 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.4 t80 -62.86 -42.39 99.74 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.282 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.3 mt -60.62 -46.46 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.416 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -63.74 -38.47 91.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.242 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.1 t90 -62.16 -42.36 99.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.768 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 28.2 mt -71.29 -43.25 67.51 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.84 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -34.74 73.06 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -70.45 -30.34 67.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.818 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.39 -22.25 0.49 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.174 -0.536 . . . . 0.0 113.243 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.02 -132.6 11.22 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.153 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.05 -30.19 90.97 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.829 2.353 . . . . 0.0 112.684 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -100.84 41.25 1.19 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.727 0.298 . . . . 0.0 111.72 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.1 -35.63 7.18 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.294 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.31 -52.85 0.59 Allowed Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.572 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -102.04 159.09 30.42 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 111.278 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 39.6 Cg_endo -67.13 163.88 32.38 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.468 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 37.0 Cg_endo -64.92 128.46 20.83 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.71 2.273 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 63.6 Cg_endo -74.06 145.97 36.16 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.86 2.374 . . . . 0.0 112.691 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.002 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.718 0.294 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.64 90.49 2.03 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.442 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.01 155.26 49.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.739 0.304 . . . . 0.0 110.983 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.18 -43.74 1.34 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.7 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 p -119.35 73.23 0.94 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.051 0.453 . . . . 0.0 110.785 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.643 ' HD2' HD23 ' A' ' 10' ' ' LEU . 43.3 m-85 -68.55 -51.31 44.24 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.742 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 98.7 m 74.01 -55.5 0.66 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.864 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.5 p -78.55 -47.98 16.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.471 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -77.19 -41.03 43.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.368 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -61.86 -38.37 88.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -63.92 -43.7 95.13 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.243 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.68 -40.13 76.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.46 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -68.55 -44.0 75.45 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.482 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -60.33 -44.46 95.48 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.311 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . 23.0 mm-40 -67.39 -41.03 85.64 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.42 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.26 -41.81 80.54 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.456 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.63 -40.73 95.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.155 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.29 -38.31 86.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.416 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 15' ' ' GLU . 35.6 t -62.52 -41.17 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.585 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -43.25 88.92 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.123 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -45.51 88.9 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.377 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.729 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.0 t80 -62.16 -41.63 98.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.319 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.2 mt -62.21 -46.8 95.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.48 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.39 -38.94 93.09 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.294 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.7 t90 -61.48 -41.81 97.84 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.615 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 64.5 mt -68.9 -42.73 76.49 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.56 74.35 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.105 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.93 -12.21 60.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.695 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.75 -6.31 4.83 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.226 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.09 -128.6 25.72 Favored Glycine 0 C--N 1.339 0.745 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.02 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -60.78 -28.55 86.64 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.641 2.228 . . . . 0.0 112.559 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -98.73 24.02 8.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.5 t -86.58 -26.62 24.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.374 0.131 . . . . 0.0 111.087 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.31 31.07 2.71 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.846 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -176.65 156.36 1.39 Allowed Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.593 0.235 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 38.4 Cg_endo -67.71 157.74 60.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.484 2.122 . . . . 0.0 112.303 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 48.3 Cg_endo -67.97 134.02 30.78 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.694 2.263 . . . . 0.0 112.361 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 72.6 Cg_endo -74.73 84.14 1.66 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.758 2.305 . . . . 0.0 112.28 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.074 -0.965 . . . . 0.0 111.086 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.2 p80 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.11 176.89 39.04 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.45 96.07 2.81 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.69 -44.74 7.13 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.617 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m 61.44 71.72 0.54 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.091 0.472 . . . . 0.0 110.913 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -122.93 12.06 9.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.846 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 m -101.25 -50.21 3.84 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.799 0.333 . . . . 0.0 110.723 179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.7 t -83.04 -40.7 19.56 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.212 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.96 -46.89 79.63 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.65 -41.09 94.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.716 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.3 t -62.89 -44.79 95.16 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.917 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -69.21 -36.54 77.38 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.162 179.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -49.99 75.58 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.898 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 27.0 mtt -58.6 -39.48 80.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.913 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' O ' HG23 ' A' ' 19' ' ' VAL . 36.2 mt-10 -66.35 -45.69 79.35 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.967 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -62.69 -45.87 90.78 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.209 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.08 -36.82 82.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.937 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.97 -38.23 90.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.204 179.693 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 15' ' ' GLU . 21.8 t -60.86 -42.88 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.742 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -43.57 83.85 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.106 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -45.25 91.31 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.361 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.644 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.1 t80 -62.35 -42.79 99.68 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.288 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 19' ' ' VAL . 52.4 mt -61.07 -45.72 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.48 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -61.79 -39.59 92.23 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.51 179.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.515 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 52.4 t90 -62.95 -38.67 92.0 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.827 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.644 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 80.2 mt -71.17 -32.28 68.71 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.803 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HD2' HG22 ' A' ' 23' ' ' ILE . 7.7 mttm -66.09 -38.06 87.31 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.342 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -75.34 -9.11 58.27 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.94 -14.58 3.81 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.358 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.74 -132.37 34.59 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.48 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.4 -31.78 81.06 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.945 2.43 . . . . 0.0 112.639 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 p -95.84 38.72 1.16 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.69 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.7 t -111.81 -33.64 6.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.213 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.15 1.24 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.608 -179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.96 153.36 41.9 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 111.265 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.72 163.74 37.95 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.823 2.349 . . . . 0.0 112.49 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.21 142.42 55.43 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.686 2.257 . . . . 0.0 112.593 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 73.6 Cg_endo -76.14 169.88 21.17 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.955 2.437 . . . . 0.0 112.626 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.505 -0.759 . . . . 0.0 110.965 179.895 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.731 0.3 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.89 -105.0 2.49 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.45 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 55.55 61.33 2.89 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.142 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.97 -45.47 1.0 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.722 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m 60.36 50.43 6.1 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.975 0.417 . . . . 0.0 110.814 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.529 ' HD1' HD12 ' A' ' 10' ' ' LEU . 54.1 p90 -89.52 -30.76 18.01 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.562 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 m -60.28 -40.22 89.62 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.481 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.9 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.091 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.6 -36.58 70.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.276 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' HD1' ' A' ' 6' ' ' PHE . 5.8 mt -60.86 -40.19 91.97 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.304 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -60.39 -44.24 95.86 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.016 179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.42 -40.96 66.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -50.63 72.69 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 14.2 mtm -57.06 -41.53 78.93 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.01 179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -62.51 -37.4 85.88 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.949 179.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.04 -37.38 76.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.194 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.31 -40.94 97.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.836 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.06 -37.65 88.19 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.27 179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.21 -46.84 89.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.577 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -61.54 -41.25 97.08 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.432 179.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.96 -45.23 86.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.271 179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.7 t80 -61.52 -42.64 99.12 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.152 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.1 mt -60.28 -46.44 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.389 179.079 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.33 -39.38 90.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.593 179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.491 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 56.6 t90 -62.68 -38.65 91.23 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.761 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.595 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 84.2 mt -70.12 -32.49 70.53 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.702 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -66.45 -32.31 73.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.445 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -84.1 7.34 19.06 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.72 -8.56 14.89 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.235 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.35 -129.59 45.64 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.554 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.08 -27.56 84.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.838 2.359 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -94.92 42.65 1.09 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.725 0.298 . . . . 0.0 111.555 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -115.82 -34.59 4.75 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.14 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.65 -43.1 1.34 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.623 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.1 153.91 39.0 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 120.679 0.276 . . . . 0.0 111.36 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.69 165.22 30.25 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.784 2.323 . . . . 0.0 112.627 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.34 138.67 43.39 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.715 2.277 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 55.8 Cg_endo -70.65 131.14 19.41 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.894 2.396 . . . . 0.0 112.402 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.759 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 m170 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.753 0.311 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.9 -54.24 0.21 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.609 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -135.12 97.48 3.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.893 0.378 . . . . 0.0 110.932 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.41 -77.91 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.85 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m 58.24 43.19 20.68 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 110.955 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.402 ' HD1' HD23 ' A' ' 10' ' ' LEU . 46.3 p90 -82.46 -27.9 31.57 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.413 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 m -51.11 -34.37 30.35 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.779 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 87.4 p -55.98 -41.47 74.85 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.727 0.299 . . . . 0.0 111.189 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.58 -34.77 27.6 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.818 179.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.402 HD23 ' HD1' ' A' ' 6' ' ' PHE . 0.3 OUTLIER -61.18 -42.64 98.93 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.368 179.967 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -61.85 -41.03 97.33 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.357 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.99 -40.15 63.17 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.197 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.66 -44.71 89.55 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.225 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 mtt -59.51 -43.66 93.34 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' O ' HG23 ' A' ' 19' ' ' VAL . 12.7 mm-40 -66.8 -42.46 85.93 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.778 179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.05 -44.63 87.53 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -39.73 92.71 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.005 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 -37.28 86.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.246 179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 15' ' ' GLU . 46.6 t -62.89 -44.88 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.666 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 mmt85 -60.04 -41.53 92.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.144 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD23 ' HB2' ' A' ' 38' ' ' PRO . 15.4 tp -65.22 -44.62 87.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.158 179.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.2 t80 -63.0 -42.09 99.75 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.304 179.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.535 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.6 mt -61.44 -45.05 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.28 -41.28 93.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.728 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 54.8 t90 -63.79 -37.32 86.95 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.813 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.616 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -71.62 -32.98 68.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.823 179.323 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.15 -37.53 87.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.475 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.6 p30 -75.65 -9.77 58.87 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.34 -18.92 3.25 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.141 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.25 -132.02 27.74 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.4 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -62.93 -28.78 75.43 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.913 2.408 . . . . 0.0 112.684 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.22 32.1 2.29 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.1 t -106.1 -34.02 7.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.033 179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.99 -45.65 1.1 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.712 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.92 153.81 39.86 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.17 165.9 29.9 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.685 2.257 . . . . 0.0 112.525 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 43.3 Cg_endo -67.05 149.71 82.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.725 2.284 . . . . 0.0 112.755 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 85.0 Cg_endo -82.55 -175.51 2.51 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.107 2.538 . . . . 0.0 112.724 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.936 179.706 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.64 0.257 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 74.46 0.24 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.434 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -111.45 135.92 51.33 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.713 0.292 . . . . 0.0 111.075 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.52 63.55 2.58 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.592 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.3 p -139.38 68.37 1.37 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.621 ' HB2' ' HB2' ' A' ' 10' ' ' LEU . 34.3 m-85 -141.79 -62.07 0.46 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.049 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 83.8 m 74.63 -56.99 0.62 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.247 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.5 p -87.3 -41.71 13.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 6' ' ' PHE . 0.4 OUTLIER -76.6 -34.78 58.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.164 179.807 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 2.6 tt -65.98 -45.51 81.41 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.921 179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 p -62.57 -38.75 91.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.975 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.86 -43.19 75.9 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -65.22 -43.55 91.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 13.7 mmt -60.87 -39.06 87.76 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.803 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.543 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -61.73 -45.63 93.1 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.948 179.608 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -35.8 78.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.091 179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -44.37 95.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.207 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.09 99.67 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.299 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 15' ' ' GLU . 31.2 t -62.11 -42.45 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.576 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.41 98.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -63.98 -44.99 91.03 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.361 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.679 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 48.2 t80 -62.02 -43.08 99.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.235 178.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.432 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.9 mt -60.81 -46.2 96.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.451 179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.39 -40.53 96.79 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.709 179.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 64.3 t90 -62.29 -36.78 83.15 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 69.6 mt -73.25 -34.15 65.69 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.662 179.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -63.27 -36.88 85.15 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -76.15 -7.76 55.52 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.47 -10.79 5.81 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.407 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 68.33 -131.48 27.23 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.606 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.65 -28.64 76.98 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 112.805 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 m -88.53 48.68 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.889 0.376 . . . . 0.0 111.254 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.6 m -138.69 11.36 2.7 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.989 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.03 36.27 92.64 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.735 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.88 137.61 10.24 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.67 0.271 . . . . 0.0 111.084 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.61 157.54 61.41 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.599 2.199 . . . . 0.0 112.825 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 63.4 Cg_endo -73.24 146.13 40.03 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.853 2.369 . . . . 0.0 112.689 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 96.5 Cg_endo -85.49 54.73 3.78 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.089 2.526 . . . . 0.0 112.318 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.805 0.336 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.52 -65.59 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.786 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -109.78 150.46 28.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.96 93.06 0.1 OUTLIER Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.965 -0.635 . . . . 0.0 112.497 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.2 m 69.9 103.02 0.06 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.742 0.306 . . . . 0.0 110.724 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.586 ' HB2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -102.19 -70.29 0.76 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.0 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 96.7 m 71.28 -56.82 0.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.176 0.59 . . . . 0.0 111.265 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -38.84 66.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.506 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -60.21 -38.54 83.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.587 -0.278 . . . . 0.0 110.939 179.71 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -62.11 -41.55 98.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.524 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.58 -41.77 91.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.162 179.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -44.74 76.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -64.34 -47.64 78.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.17 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -41.03 82.14 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.989 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -61.67 -45.27 94.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.768 179.462 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.89 -40.05 87.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.908 179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -62.68 -40.58 97.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.933 179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.59 89.57 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.004 179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 15' ' ' GLU . 59.1 t -62.51 -43.39 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.699 179.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -60.59 -44.11 96.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.752 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.9 mt -63.14 -44.35 95.82 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.399 179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 56.1 t80 -62.61 -42.1 99.38 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.221 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.1 mt -60.94 -45.38 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -63.02 -38.71 92.27 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.551 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.5 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 62.3 t90 -63.57 -39.93 95.66 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.542 179.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.581 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 40.3 mt -70.41 -32.02 69.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.53 179.094 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -65.94 -36.73 84.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.226 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.3 p30 -78.33 -3.11 41.37 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.57 -15.92 5.43 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.092 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.05 -129.26 34.92 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.324 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.31 -28.2 78.56 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.771 2.314 . . . . 0.0 112.814 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.2 t -96.84 37.74 1.28 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.691 0.281 . . . . 0.0 111.692 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.5 t -113.96 -32.2 6.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.297 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.52 -45.32 1.15 Allowed Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.719 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.35 153.65 44.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 120.702 0.287 . . . . 0.0 111.356 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 162.95 40.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.832 2.355 . . . . 0.0 112.596 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 50.4 Cg_endo -69.12 136.98 36.17 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.711 2.274 . . . . 0.0 112.635 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.9 Cg_endo -72.88 108.54 2.6 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.763 2.309 . . . . 0.0 112.207 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.859 -179.937 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.593 0.235 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 139.96 -93.79 0.19 Allowed Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.468 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -136.06 154.02 51.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.81 0.338 . . . . 0.0 111.481 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.97 -76.34 0.95 Allowed Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.581 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.7 m 57.49 41.15 26.44 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.944 0.402 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -101.48 -29.74 11.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.423 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 m -57.21 -34.85 68.95 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.547 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -44.26 90.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.104 179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -76.34 -38.31 56.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.267 179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.31 -37.78 88.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.226 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -70.47 -32.32 69.8 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.746 0.307 . . . . 0.0 110.709 179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -74.87 -44.97 46.08 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.683 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -59.88 -41.68 92.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.492 0.187 . . . . 0.0 111.314 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 20.1 mmt -68.45 -34.77 76.56 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.586 179.253 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -70.27 -44.29 68.73 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.21 179.664 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -60.42 -44.63 95.57 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -61.83 -41.12 97.4 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.997 179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -40.74 97.95 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.253 179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 15' ' ' GLU . 59.0 t -64.64 -43.01 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.479 179.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -42.9 99.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.72 -43.74 92.46 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.412 179.258 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 51.1 t80 -63.23 -43.27 98.53 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.23 179.015 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' CD1' HG12 ' A' ' 19' ' ' VAL . 44.7 mt -61.1 -45.02 99.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.447 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -65.77 -37.74 87.14 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.677 179.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 68.1 t90 -63.13 -36.21 82.86 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.657 179.294 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.594 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 75.6 mt -73.1 -32.78 65.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.691 179.209 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -68.61 -30.82 69.64 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.817 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 20.2 p30 -84.25 7.47 19.07 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.57 -0.5 20.25 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.504 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.67 -129.11 49.16 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.519 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 -33.48 92.81 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.964 2.443 . . . . 0.0 112.824 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t -91.0 53.32 2.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.973 0.416 . . . . 0.0 111.305 -179.781 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.0 t -122.62 -37.24 2.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.361 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 136.21 -41.27 1.44 Allowed Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.486 -179.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.78 154.91 37.66 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 120.66 0.267 . . . . 0.0 111.263 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 164.9 32.33 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.698 2.265 . . . . 0.0 112.659 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 51.9 Cg_endo -69.57 133.65 26.44 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.758 2.305 . . . . 0.0 112.631 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 54.6 Cg_endo -70.61 -40.47 3.97 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.756 2.304 . . . . 0.0 112.466 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.04 179.764 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.103 0.477 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.02 111.73 1.72 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -92.09 165.67 13.05 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 111.269 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.45 62.9 0.2 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.576 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m 57.32 62.35 2.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.056 0.455 . . . . 0.0 110.905 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -91.73 -29.62 16.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.415 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 p -57.21 -37.11 71.71 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.563 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.9 m -60.08 -46.63 88.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.858 0.361 . . . . 0.0 111.015 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -73.89 -34.65 64.5 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.149 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.443 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 3.2 tt -63.78 -41.09 98.01 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.991 179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.8 m -68.08 -25.39 65.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.124 179.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -81.06 -47.29 13.75 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.437 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 10' ' ' LEU . 3.4 pp0? -62.88 -40.09 96.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.455 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -32.43 70.78 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.54 0.21 . . . . 0.0 110.905 179.483 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -69.96 -40.61 75.32 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.904 179.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -57.21 -39.96 76.5 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -61.27 -39.79 91.7 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.225 179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.91 -43.48 88.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.404 HG12 ' CD1' ' A' ' 23' ' ' ILE . 43.9 t -62.66 -45.75 98.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.699 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -40.22 94.78 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.667 179.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -44.53 83.48 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.373 179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 46.6 t80 -62.94 -42.22 99.74 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.276 178.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.404 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.4 mt -61.99 -46.93 95.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.341 178.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -63.26 -38.2 90.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.305 179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.451 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 64.8 t90 -61.17 -43.26 99.16 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.64 179.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.674 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 81.2 mt -68.04 -39.65 83.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.778 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -63.65 -30.29 71.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.739 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.29 1.58 31.87 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.814 179.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.82 1.07 15.04 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.157 -179.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.8 -126.76 39.82 Favored Glycine 0 C--N 1.34 0.76 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.345 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -59.39 -28.59 87.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.678 2.252 . . . . 0.0 112.703 179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 t -98.34 30.75 3.05 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -91.88 -39.33 11.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.5 0.19 . . . . 0.0 110.882 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 145.82 -44.89 0.84 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.592 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -110.8 164.95 13.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.694 0.283 . . . . 0.0 110.993 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 42.0 Cg_endo -68.06 164.76 30.74 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.675 2.25 . . . . 0.0 112.381 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 36.8 Cg_endo -65.99 126.67 16.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.69 2.26 . . . . 0.0 112.539 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 65.8 Cg_endo -75.55 106.08 2.2 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.815 2.343 . . . . 0.0 112.204 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.252 1.188 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.636 -179.772 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.494 0.188 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.8 54.31 0.57 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.709 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 1.9 tp10 -167.8 146.62 4.73 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.733 0.301 . . . . 0.0 111.315 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 116.05 110.44 2.7 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.18 179.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 m 67.66 99.89 0.05 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.725 0.41 . . . . 0.0 112.046 179.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 63.26 12.93 6.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.436 ' HB ' ' HA ' ' A' ' 3' ' ' GLU . 1.6 m -105.43 -44.25 4.76 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.628 0.251 . . . . 0.0 110.884 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -68.94 -43.61 74.73 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.41 -46.63 75.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.879 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 m -61.89 -40.37 95.19 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.896 179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -42.29 86.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.988 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -66.34 -45.16 81.14 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.077 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 44.4 mtm -61.73 -45.77 92.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.932 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.79 -35.44 80.08 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.6 -42.82 83.99 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.142 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.2 -41.91 94.01 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.937 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.54 -40.32 96.71 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.955 179.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' GLU . 48.1 t -63.55 -43.93 98.48 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.314 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -43.87 92.31 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.665 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 mp -63.45 -44.56 94.16 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 179.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 54.0 t80 -61.75 -40.93 96.85 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.241 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.476 HG22 ' HE2' ' A' ' 27' ' ' LYS . 47.7 mt -61.42 -46.89 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.406 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.95 -39.49 92.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.482 179.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 55.7 t90 -61.35 -43.41 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.651 179.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.606 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 44.3 mt -66.92 -41.29 87.34 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.824 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.476 ' HE2' HG22 ' A' ' 23' ' ' ILE . 11.9 mttm -61.72 -34.27 75.5 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.766 179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -71.12 -22.75 62.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.148 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.72 -15.89 2.0 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.981 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.76 -133.7 16.02 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.218 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.73 -29.31 89.37 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.856 2.371 . . . . 0.0 112.566 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -102.02 23.71 11.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 t -87.37 -38.82 15.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.538 0.209 . . . . 0.0 110.982 179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.58 -45.67 0.71 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.596 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.6 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -110.22 162.85 18.8 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.687 0.28 . . . . 0.0 111.242 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.6 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 47.9 Cg_endo -69.34 165.64 29.78 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.759 2.306 . . . . 0.0 112.366 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.446 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.7 Cg_endo -66.04 138.39 52.11 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.74 2.294 . . . . 0.0 112.582 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 58.1 Cg_endo -71.75 116.55 4.75 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.803 2.336 . . . . 0.0 112.548 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.781 179.871 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.703 0.287 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.07 52.72 50.34 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -104.06 154.95 19.1 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.722 0.296 . . . . 0.0 111.058 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.45 -56.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.559 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m 62.8 79.93 0.24 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.984 0.421 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 10' ' ' LEU . 1.4 m-85 -94.88 11.38 31.89 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.849 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -103.49 -36.69 7.88 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.559 0.218 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.8 m -87.72 -47.34 8.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.233 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.18 -48.88 66.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.524 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -61.2 -39.69 91.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.066 179.755 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.9 t -64.98 -40.16 94.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.033 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -66.9 -40.11 87.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.014 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.73 -43.93 78.8 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.05 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.458 ' HG3' HD23 ' A' ' 10' ' ' LEU . 28.8 mtt -67.47 -24.77 65.64 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.569 179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -84.31 -37.02 22.16 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 179.62 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -63.19 -44.64 94.81 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.476 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -35.02 72.58 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.265 179.768 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.34 86.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 179.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 23' ' ' ILE . 65.7 t -59.82 -48.23 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.66 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -43.23 75.03 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.33 -41.99 90.41 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 37.2 t80 -66.23 -36.31 82.71 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.051 178.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 19' ' ' VAL . 6.7 mm -61.75 -48.05 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.342 178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -60.47 -39.94 89.42 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.642 179.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.483 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 51.9 t90 -60.22 -42.65 95.63 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.5 mt -67.78 -40.34 83.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.796 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.67 -34.63 76.06 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 179.56 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -71.66 -21.32 61.83 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.084 179.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.51 -15.46 2.04 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.328 -0.463 . . . . 0.0 112.924 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.12 -133.24 14.62 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.174 -179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.09 -29.87 90.16 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.77 2.314 . . . . 0.0 112.643 179.786 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 p -99.86 17.24 21.32 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -80.0 -39.58 29.72 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.506 0.193 . . . . 0.0 110.87 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 148.79 -48.26 0.62 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.469 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.559 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -107.18 161.55 22.61 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 120.782 0.325 . . . . 0.0 111.281 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 41.0 Cg_endo -67.48 165.62 26.56 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.734 2.29 . . . . 0.0 112.457 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 39.6 Cg_endo -65.85 143.15 72.31 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.732 2.288 . . . . 0.0 112.836 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.4 Cg_endo -80.87 67.71 8.56 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.988 2.459 . . . . 0.0 112.47 179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.021 -179.96 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.492 0.186 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.3 -82.81 1.61 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.403 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -111.32 98.41 7.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.838 0.351 . . . . 0.0 110.776 179.887 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.4 39.06 1.06 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.7 t -156.79 38.55 0.32 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.926 0.393 . . . . 0.0 111.104 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -103.72 -44.8 4.98 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.826 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 m -72.96 -44.88 60.6 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.073 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 56.7 m -63.55 -42.73 98.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.209 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -67.82 -41.31 83.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -42.19 98.72 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.965 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -61.1 -40.34 93.38 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.097 179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -45.61 66.76 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.257 179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -65.94 -46.91 76.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.125 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 34.6 mmt -62.28 -29.98 70.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.728 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -70.33 -43.98 69.17 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.969 179.635 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 -53.74 53.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.239 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -32.39 72.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.15 77.81 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.238 179.398 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 15' ' ' GLU . 97.8 t -61.62 -45.52 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.963 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -42.66 95.98 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.776 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 21' ' ' LEU . 2.3 mm? -64.75 -43.84 92.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 179.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 57.7 t80 -62.13 -41.49 98.3 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.233 178.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.401 ' CD1' HG12 ' A' ' 19' ' ' VAL . 42.0 mt -60.84 -47.86 91.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.381 179.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -63.06 -38.16 90.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.373 179.103 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.506 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 63.8 t90 -61.13 -42.16 98.03 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.453 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 86.1 mt -67.5 -40.78 85.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.753 179.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -33.25 74.98 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.904 179.502 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.17 -7.35 53.58 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.746 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.08 1.41 8.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.228 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.41 -128.26 43.45 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.448 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.47 -27.26 84.53 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.706 2.271 . . . . 0.0 112.462 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.3 t -96.64 22.81 7.6 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.812 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -86.45 -40.2 15.57 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.606 0.241 . . . . 0.0 110.644 179.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 138.76 -48.0 0.89 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.356 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -97.43 160.25 29.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.608 0.242 . . . . 0.0 111.021 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 40.7 Cg_endo -67.08 160.98 44.78 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.65 2.233 . . . . 0.0 112.528 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.506 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 45.2 Cg_endo -68.42 129.56 19.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.851 2.367 . . . . 0.0 112.675 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 92.2 Cg_endo -85.43 54.75 3.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.022 2.482 . . . . 0.0 112.331 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.059 -179.86 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 21.1 m80 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 120.731 0.301 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -74.42 1.28 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.555 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -105.0 152.09 23.15 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.771 0.319 . . . . 0.0 111.154 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.11 -107.16 0.66 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.509 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.9 p -128.08 74.35 1.54 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -89.52 -29.57 18.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.461 179.936 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -56.73 -34.18 67.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.534 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -58.02 -43.69 86.88 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.76 179.561 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -31.18 64.31 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.102 179.354 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.65 -46.7 88.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.192 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 m -60.21 -41.62 93.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.064 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -69.54 -44.1 71.63 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.106 179.739 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -63.61 -41.31 98.31 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.484 -179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -49.12 76.68 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.991 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -70.45 -39.74 74.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.691 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 2.1 tt0 -58.96 -36.0 74.11 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.523 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.04 -45.51 86.87 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.341 179.93 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.95 -47.57 65.33 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 23' ' ' ILE . 61.8 t -61.5 -42.32 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.491 179.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.78 -42.78 99.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 179.429 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.33 -44.17 95.65 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.305 179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.688 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 40.6 t80 -63.97 -43.88 94.43 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.22 179.116 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 19' ' ' VAL . 50.7 mt -61.65 -45.33 98.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.349 179.081 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -63.79 -37.83 88.83 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.398 179.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 63.0 t90 -63.19 -39.02 93.44 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.612 179.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 88.5 mt -71.84 -34.63 69.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.563 179.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -65.12 -36.95 85.89 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.472 179.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -76.66 -8.86 58.07 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.13 -8.39 4.43 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.632 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.38 -132.24 41.82 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.468 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.23 -30.76 74.44 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.893 2.395 . . . . 0.0 112.762 -179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 p -93.33 41.49 1.08 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.621 -179.733 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -115.29 -33.7 5.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.247 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 141.11 -44.82 1.0 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -107.61 157.28 36.2 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.61 0.243 . . . . 0.0 111.504 -179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 56.5 Cg_endo -70.57 169.53 19.73 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.768 2.312 . . . . 0.0 112.441 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.2 144.39 81.04 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.643 2.229 . . . . 0.0 112.838 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 25' ' ' TRP . 52.2 Cg_endo -69.75 154.96 67.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.0 2.466 . . . . 0.0 112.655 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.944 179.847 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.743 0.306 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.69 -41.41 1.63 Allowed Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.6 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 65.15 79.54 0.25 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.045 0.45 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.52 -77.12 1.31 Allowed Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.375 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -107.47 49.18 0.81 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 110.544 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -93.54 7.8 43.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.743 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -109.45 -35.62 6.2 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.579 0.228 . . . . 0.0 111.205 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 t -91.75 -45.24 8.53 Favored 'General case' 0 CA--C 1.527 0.092 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.145 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -71.31 -44.79 64.46 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.235 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 tt -62.15 -45.48 93.25 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.752 179.817 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.2 p -61.47 -36.83 81.53 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.023 179.655 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -67.59 -43.92 79.35 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.982 179.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -70.1 -45.08 67.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.027 179.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -45.72 90.72 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.949 179.78 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -67.08 -38.42 85.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.12 179.685 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.73 -40.21 75.31 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.177 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.56 -40.88 88.75 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.611 179.466 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.19 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.943 179.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.436 HG12 ' CD1' ' A' ' 23' ' ' ILE . 32.4 t -60.41 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.756 179.687 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -44.18 90.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.714 179.385 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -44.67 93.92 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.411 179.168 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 55.3 t80 -62.13 -42.85 99.65 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.167 179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.436 ' CD1' HG12 ' A' ' 19' ' ' VAL . 45.3 mt -61.14 -46.93 95.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 178.923 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 18.5 tt0 -64.6 -36.88 85.68 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.473 178.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.4 t90 -64.68 -38.16 90.04 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.798 179.462 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 54.6 mt -71.15 -45.88 62.64 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.376 179.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.72 -26.24 68.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.314 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.82 -3.58 48.4 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.64 179.405 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.79 2.5 10.4 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.047 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.92 -127.68 44.74 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.449 -179.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.41 -29.32 89.84 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.754 2.303 . . . . 0.0 112.56 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.8 t -98.92 38.49 1.37 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.601 -179.936 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -101.81 -38.82 7.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.816 179.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 144.32 -50.14 0.67 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -100.82 163.49 17.96 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.68 0.276 . . . . 0.0 111.067 179.699 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 57.0 Cg_endo -71.03 163.25 39.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.575 2.184 . . . . 0.0 112.398 179.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 38.2 Cg_endo -66.54 125.31 13.67 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.594 2.196 . . . . 0.0 112.565 -179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 59.8 Cg_endo -73.08 106.05 2.08 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.827 2.351 . . . . 0.0 112.114 179.859 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.703 -179.514 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.4 t60 . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.31 -123.02 2.48 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.48 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.54 56.1 1.86 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.074 0.464 . . . . 0.0 110.94 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.01 55.93 0.02 OUTLIER Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.755 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -132.64 25.86 4.38 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.719 0.295 . . . . 0.0 111.238 179.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.81 -25.83 22.02 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.591 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 t -57.58 -37.07 72.58 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.563 0.22 . . . . 0.0 111.168 179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -89.5 -39.44 13.33 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.073 179.567 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.08 -41.26 99.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 ' HA ' ' HG2' ' A' ' 13' ' ' GLN . 7.9 tp -63.02 -38.5 91.42 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.001 179.754 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.2 m -61.68 -36.55 81.18 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.045 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -71.87 -48.85 42.95 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.302 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 10' ' ' LEU . 13.3 pt20 -66.29 -33.27 75.35 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 12.1 mmm -70.14 -35.8 74.32 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.569 179.366 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.98 -47.83 34.58 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.081 179.573 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 12.6 pt-20 -58.95 -35.69 73.55 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -39.73 80.69 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.794 179.402 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.26 -42.37 79.74 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.044 179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 23' ' ' ILE . 78.1 t -61.39 -45.03 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.73 179.488 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -41.89 95.83 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.495 179.453 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.47 -43.04 91.5 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.327 179.1 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 52.3 t80 -63.51 -42.77 98.46 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.163 179.009 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.44 ' CD1' HG12 ' A' ' 19' ' ' VAL . 46.5 mt -60.25 -46.69 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.31 178.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.94 -37.61 88.23 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.386 178.894 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 37' ' ' PRO . 72.0 t90 -63.68 -36.17 82.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.776 179.591 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 42.3 mt -74.83 -35.97 62.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.636 0.255 . . . . 0.0 110.85 179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -64.73 -36.61 84.87 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.626 179.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 18.8 p30 -75.2 -10.17 59.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.21 -10.77 4.43 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.475 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.11 -130.28 32.62 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.369 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.13 -25.41 72.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.815 2.343 . . . . 0.0 112.781 179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -93.85 34.97 1.17 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.66 0.267 . . . . 0.0 111.649 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.2 t -112.61 -32.03 6.58 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.116 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.67 -44.13 1.31 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.131 -0.556 . . . . 0.0 112.699 -179.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.74 151.76 50.53 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 120.584 0.231 . . . . 0.0 111.303 179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 160.61 48.92 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.75 2.3 . . . . 0.0 112.541 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.5 ' HB3' ' CH2' ' A' ' 25' ' ' TRP . 56.1 Cg_endo -70.27 130.31 18.5 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.788 2.325 . . . . 0.0 112.654 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 61.0 Cg_endo -73.11 109.29 2.8 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.766 2.311 . . . . 0.0 112.401 179.792 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.6 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.121 -0.943 . . . . 0.0 111.136 -179.961 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.49 0.186 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.79 -58.1 1.13 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 68.56 155.96 0.12 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.959 0.409 . . . . 0.0 111.495 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.3 65.31 2.28 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.49 -179.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.2 p -123.97 -120.53 0.27 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.688 0.28 . . . . 0.0 110.481 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -79.69 -29.41 40.74 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.378 179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -59.88 -38.78 83.19 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.59 -179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.9 p -64.1 -42.65 96.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.174 179.844 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -37.05 69.53 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 179.57 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -35.79 80.77 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.005 179.75 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.8 m -60.16 -42.84 95.78 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 179.655 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.91 -34.07 62.1 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.001 179.599 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.537 ' HA ' ' HG2' ' A' ' 16' ' ' GLU . 0.6 OUTLIER -67.62 -31.97 72.36 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.28 179.734 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 22.8 mtp -77.27 -31.46 54.93 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.605 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.9 tp10 -79.25 -40.13 31.36 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.392 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.537 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.55 -35.48 76.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.406 0.15 . . . . 0.0 111.406 -179.746 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -71.38 -38.45 71.53 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.696 0.284 . . . . 0.0 110.813 179.512 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.92 89.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.759 179.254 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 15' ' ' GLU . 92.4 t -64.97 -44.7 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.487 179.292 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -61.32 -42.0 97.95 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.65 179.251 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -64.65 -45.65 85.87 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.451 179.263 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 49.9 t80 -62.75 -42.49 99.7 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.282 179.171 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CD1' HG12 ' A' ' 19' ' ' VAL . 54.3 mt -61.7 -45.12 99.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 178.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -63.32 -38.18 90.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.318 179.129 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.539 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 61.7 t90 -62.72 -41.89 99.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.512 179.296 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 76.8 mt -69.46 -34.04 73.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.611 179.093 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -64.09 -39.5 94.19 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 13.7 p30 -74.38 -10.68 59.81 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.846 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 137.04 -12.42 3.87 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.522 179.9 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -131.21 45.32 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.102 -179.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.17 -35.22 42.68 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.705 2.27 . . . . 0.0 112.362 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -70.67 -21.09 62.63 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.93 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -64.02 -26.49 68.59 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.63 37.6 4.44 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.72 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.86 147.22 15.95 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 110.739 179.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.62 155.35 70.46 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.382 2.054 . . . . 0.0 112.817 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.97 136.19 26.88 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.886 2.391 . . . . 0.0 112.609 -179.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 37.3 Cg_endo -66.92 -44.53 5.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.907 2.405 . . . . 0.0 112.389 179.778 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 6.8 t . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.437 -0.792 . . . . 0.0 111.059 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 150.39 101.85 0.24 Allowed Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.517 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.26 121.55 19.2 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.665 0.269 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.85 7.1 45.19 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.438 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 t 38.73 66.56 0.51 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.17 0.509 . . . . 0.0 111.88 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.35 -32.94 69.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.598 -179.927 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -59.65 -49.52 77.44 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -38.86 81.2 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -40.1 95.64 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.275 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.15 -40.12 94.91 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.896 179.77 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.6 m -62.84 -45.09 94.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.046 179.653 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -40.18 94.08 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -66.15 -46.16 78.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.101 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mtt -62.43 -45.09 94.66 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.933 179.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 19' ' ' VAL . 37.7 mt-10 -66.65 -35.0 79.12 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.786 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -56.95 -38.91 73.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.415 179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.14 -45.25 93.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.221 179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.85 -38.94 92.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.202 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 15' ' ' GLU . 48.6 t -61.9 -39.81 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.487 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -58.25 -44.3 88.26 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.998 179.45 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.8 mp -63.4 -46.43 86.46 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.376 179.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.0 t80 -60.76 -41.23 95.03 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.277 179.041 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.504 ' CD1' HG12 ' A' ' 19' ' ' VAL . 43.8 mt -61.17 -48.4 89.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.438 179.119 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -60.56 -38.24 83.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.723 179.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.507 ' HA ' ' ND2' ' A' ' 28' ' ' ASN . 60.6 t90 -63.15 -39.32 94.34 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.723 179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.614 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 52.1 mt -70.55 -33.5 71.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.005 179.331 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -37.99 88.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.365 179.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 25' ' ' TRP . 17.2 p30 -74.52 -12.2 60.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.42 -17.53 2.88 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.267 179.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.06 -131.54 30.6 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.445 -179.873 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.27 -27.79 72.25 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 0.0 112.869 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.51 26.83 3.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.692 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -103.35 -32.1 9.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.381 0.134 . . . . 0.0 111.106 179.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.5 -46.28 1.09 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.644 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.34 154.19 46.57 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.814 0.34 . . . . 0.0 111.381 -179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.2 164.18 36.43 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.834 2.356 . . . . 0.0 112.534 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.04 136.53 38.25 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.64 2.227 . . . . 0.0 112.629 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.51 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 56.7 Cg_endo -70.91 139.16 35.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.901 2.401 . . . . 0.0 112.577 179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.436 -0.793 . . . . 0.0 110.905 179.873 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.981 0.419 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.47 171.29 33.31 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.717 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.02 -178.25 6.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.618 0.246 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.03 30.84 4.03 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.831 179.866 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.5 m -152.08 91.07 1.58 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.897 0.38 . . . . 0.0 110.477 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.534 ' O ' ' HB ' ' A' ' 7' ' ' THR . 89.3 m-85 -117.13 -49.91 2.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.315 -179.676 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 6' ' ' PHE . 53.4 m 75.96 -55.88 0.6 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.743 0.652 . . . . 0.0 111.276 -179.437 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 p -84.75 -43.79 13.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.823 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.18 -37.37 57.97 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.128 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD23 ' HD2' ' A' ' 6' ' ' PHE . 0.2 OUTLIER -63.86 -43.86 94.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.908 179.857 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -60.53 -39.72 88.9 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.013 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -67.53 -42.68 82.33 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.727 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -63.08 -40.7 98.44 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.399 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 11.0 mtp -58.3 -45.83 87.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.024 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' O ' HG23 ' A' ' 19' ' ' VAL . 35.9 mt-10 -73.63 -36.09 65.4 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -58.0 -42.02 84.32 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.172 179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -59.68 -39.9 86.07 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.928 179.748 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.32 -37.48 87.23 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 15' ' ' GLU . 32.3 t -63.78 -47.54 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.557 179.539 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -43.54 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.712 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 -44.62 90.57 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.349 179.119 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 61.8 t80 -62.04 -41.76 98.45 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.285 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -61.28 -46.57 96.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.449 179.054 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -63.88 -37.51 87.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.449 179.146 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 46.8 t90 -60.74 -44.15 97.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.452 179.158 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 61.0 mt -68.76 -39.37 80.32 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.813 179.435 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -60.31 -36.78 78.7 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.456 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.13 -28.3 64.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.446 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.93 -20.53 0.77 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.185 -0.531 . . . . 0.0 113.056 -179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.18 -133.58 12.27 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.04 -179.818 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.42 -31.63 95.12 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.69 2.26 . . . . 0.0 112.656 179.818 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.23 33.7 3.2 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.711 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.9 t -97.53 -38.64 9.49 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.545 0.212 . . . . 0.0 110.952 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.39 -53.33 0.54 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.505 -179.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.464 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -98.75 158.26 32.77 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.578 0.228 . . . . 0.0 111.122 179.866 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 46.0 Cg_endo -69.1 165.36 30.48 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.719 2.279 . . . . 0.0 112.661 -179.901 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.01 132.97 33.87 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.624 2.216 . . . . 0.0 112.393 -179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HG2' ' HA ' ' A' ' 22' ' ' PHE . 52.3 Cg_endo -69.59 151.09 69.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.861 2.374 . . . . 0.0 112.621 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.638 -0.696 . . . . 0.0 111.392 179.943 . . . . . . . . 0 0 . 1 stop_ save_